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Summary
 Gene expression is the process by which the information encoded in a 
gene is used to direct the synthesis of a protein. Several steps in the gene 
expression, including transcription, mRNA processing, nuclear mRNA export, 
translation and mRNA degradation are regulated and closely linked. In the 
budding yeast S. cerevisiae the conserved TREX (transcription/export) 
complex travels along the transcribed gene with RNA polymerase II (RNAPII) 
and couples transcription to nuclear mRNA export. Even though the TREX 
complex has been identified and studied extensively during the last decade, it 
is still unclear how  the complex is recruited to the active transcription 
machinery. 
 Here I show that the Prp19 complex, a conserved non-snRNP 
spliceosome component essential for splicing, genetically and biochemically 
interacts with the TREX complex. The Prp19 complex is recruited to 
transcribed genes, interacts with RNAPII as well as the TREX complex and is 
absolutely required for the occupancy of the TREX complex at transcribed 
genes. Moreover, the C-terminus of Syf1, one of essential components of the 
Prp19 complex, is necessary for the occupancy of the Prp19 complex at 
transcribed genes as well as the interaction of the Prp19 complex with 
RNAPII. Importantly, the Prp19 complex is necessary for full transcriptional 
activity both in vitro and in vivo. Taken together, I identify the Prp19 splicing 
complex as a novel transcription elongation factor which is essential for TREX 
occupancy at transcribed genes and thus provide a novel link between 
transcription and messenger ribonucleoprotein (mRNP) formation.
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1. Introduction
In the past decades, many studies have revealed that several steps in gene 
expression are intimately connected and form a complex network. The close 
coupling processes within this sophisticated system include transcription, 
capping, splicing, polyadenylation, cleavage, mRNA maturation, mRNA export, 
translation and ultimately mRNA degradation. To ensure efficient and accurate 
gene expression of the genetic information, the interplay between those 
procedures has to be highly regulated in living cells. (for review see Maniatis 
and Reed 2002; Proudfoot et al. 2002; Reed and Hurt 2002; Cole and 
Scarcelli 2006).
1.1 Transcription
Transcription is the first step leading to gene expression. It is the process of 
creating a complementary RNA copy of a DNA sequence. During transcription, 
a sequence of DNA is transcribed by RNA polymerases. In eukaryotes, when 
the gene transcribed encodes a protein, the result of transcription is 
messenger RNA (mRNA) which is transcribed by a specific RNA polymerase 
known as RNA polymerase II (RNAPII). 
Transcription by RNAPII is facilitated by a large number of transcription 
factors. Transcription initiation factors control transcription and recruit RNAPII 
to a promoter. When RNAPII begins to synthesize the mRNA, transcription 
initiation factors are substituted with transcription elongation factors (Pokholok 
et al. 2002). Transcription elongation factors enhance the rate of transcription 
and/or increase the processivity, the ability of elongating RNAPII to travel the 
entire length of the gene, by facilitating chromatin passage and mRNA 
processing (Hirose and Manley 2000; Orphanides and Reinberg 2000; 
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Orphanides and Reinberg 2002; Ahn et al. 2004; Mason and Struhl 2005; 
Perales and Bentley 2009).
1.2 Transcription, nuclear mRNA export and TREX
Several genetic and biochemical approaches showed the existence of an 
extensive network between the factors which couple transcription with other 
processes, e.g. nuclear mRNA export. A key player in coupling transcription 
and nuclear mRNA export is the highly conserved TREX complex (Strasser et 
al. 2002). In budding yeast, TREX is composed of the heterotetrameric THO 
subcomplex, the two mRNA export proteins Sub2 and Yra1, the two SR-like 
proteins Gbp2 and Hrb1 and a protein of unknown function Tex1. THO, 
consisting of Tho2, Thp2, Mft1 and Hpr1, is associated with actively 
transcribed genes and is necessary for efficient transcription elongation in 
vivo. (Chavez and Aguilera 1997; Piruat and Aguilera 1998; Chavez et al. 
2000; Strasser et al. 2002). Even though THO components are not essential 
in yeast, the lack of them leads to a DNA/RNA hybrid formation, so-called R-
loop, which causes an elongation block for the next elongating RNAPII 
(Huertas et al. 2006). The THO complex has also been implicated in a crucial 
network between transcription, RNA quality control and genome stability 
(Jimeno et al. 2002) as THO mutants show  transcription-dependent 
hyperrecombination. This hyperrecombination phenotype might be a 
secondary effect of a defect in transcription elongation which causes exposure 
of the transcribed DNA template to the recombination machineries (Reed 
2003). Importantly, THO is also necessary to load the mRNA export proteins 
Sub2 and Yra1 co-transcriptionally onto the nascent mRNA for its subsequent 
nuclear export (Strasser et al. 2002; Abruzzi et al. 2004). Sub2 is a DECD-box 
RNA helicase which is involved in both splicing and mRNA export. Sub2 
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interacts with and recruits the mRNA export factor Yra1, which is able to bind 
directly to the mRNA (Portman et al. 1997), to the nascent transcript (Strasser 
and Hurt 2001). The SR-like proteins Gbp2 and Hrb1 associate with TREX 
and with actively transcribed genes. Even though their involvement in mRNA 
export has not been elucidated, they interact with and are exported together 
with nascent mRNA to the cytoplasm in a THO-dependent manner. (Hacker 
and Krebber 2004; Hurt et al. 2004). 
Figure 1.1: TREX couples transcription and mRNA export
TREX consists of the heterotetrameric THO complex, comprising Tho2, Hpr1, Mft1, 
and Thp2, the nuclear mRNA export factors Sub2 and Yra1, the SR-like proteins 
Gbp2 and Hrb1, and Tex1. TREX travels along the transcribed gene with RNAPII, 
interacts with the nascent mRNA and directs it into the mRNA export pathway via the 
mRNA export factors Sub2 and Yra1. Yra1 then directly binds the mRNA exporter 
Mex67-Mtr2, which in turn binds directly  to the mRNA as well as to nuclear pore 
proteins and transports the mRNP through the nuclear pore complex to the 
cytoplasm
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1.3 Splicing and recruitment of the TREX complex
Pre-mRNA splicing is an important process and plays a crucial role in the 
regulation of gene expression. The splicing reaction is catalyzed by 
spliceosome, which is composed of five small nuclear RNAs (snRNAs), U1, 
U2, U4, U5, and U6 in the forms of small nuclear ribonucleoprotein (snRNP) 
complexes (Will and Lührmann 1997, 2006; Staley and Guthrie 1998; Burge et 
al. 1999; Wahl et al. 2009). Spliceosome assembly is a stepwise process 
which involves sequential interaction of snRNPs and other protein 
components.
The spliceosome assembly begins with the recognition of the 5'-splice site by 
U1 snRNP and the polypyrimidine tract by the U2 snRNP auxiliary factor 
(U2AF), which initiates the formation of an ATP-independent early complex (E 
complex). The interaction of U2AF to the polypyrimidine tract recruits the U2 
snRNP to the branch point sequence, forming the A complex. Next, the B 
complex is formed by the association of the U4/U6.U5 tri-snRNP. 
Subsequently, a series of protein/RNA rearrangements alter the B complex to 
the C complex, an active and transient spliceosome intermediate. These 
short-lived spliceosomal complexes can be distinguished by their snRNP 
compositions as shown in Figure 1.2.
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Figure 1.2: The stepwise spliceosome assembly
During spliceosome assembly, firstly the U1 snRNP associates with the pre-mRNA 
forming the E complex. Then the U2 snRNP binds and forms the A complex. 
Recruitment of the pre-assembled U4/U6.U5 tri-snRNP leads to formation of the pre-
catalytic B complex. By structural rearrangements, the U1 and U4 snRNPs 
dissociate and incorporation of the Prp19 complex leads to remodeling of U5 and 
formation of the activated B complex. The C complex is formed after the first step of 
splicing occurs. Subsequently, the second step of splicing takes place. Finally, the 
mature mRNA and the post-spliceosomal complex are released as well as the 
splicing factors are recycled.
Even though the gene expression machineries are highly conserved from 
yeast to metazoans, a fundamental difference between these organisms is 
that most yeast genes lack introns whereas the converse is true in higher 
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Figure 1.3: Model of mRNA export in yeast and human
In the yeast S. cerevisiae, mRNA export is coupled to transcription (left panel), 
whereas in higher eukaryotes it is coupled to splicing in a cap-dependent manner 
(right panel). In yeast, the THO subcomplex is recruited to the nascent mRNA during 
ongoing transcription and recruits the mRNA export factors Sub2 and Yra1. Then 
Mex67-Mtr2 binds to the mRNP through the interaction with Yra1 and transports the 
mRNP through the nuclear pore complex (left panel). In higher eukaryotes, the 
TREX complex, together with the exon-exon junction complex (EJC), is recruited to 
the mRNA during splicing (right panel). As in yeast, the mRNA is exported to the 
cytoplasm by the interaction of Aly, the human homolog of Yra1, with Tap-p15, the 
human homolog of yeast Mex67-Mtr2.
organisms. In human cells, where most of protein-encoding genes contain
introns and have to be spliced, it has been shown that TREX complex is 
recruited to transcribed genes during splicing instead of transcription. In vitro 
studies of spliceosome assembly and subsequent proteomic analyses 
revealed that human TREX associates with the C complex (Wahl et al. 2009). 
However, in yeast, the TREX complex appears to be recruited by the 
transcription machinery in a splicing-independent manner (Figure 1.3). Even 
though the function of the TREX complex is conserved, its recruitment is not. 
It has been a longstanding question how  the TREX complex is recruited to 
transcribed genes and which factors are required for this recruitment. 
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1.4 Splicing and the Prp19 complex 
The spliceosome assembly is a strictly ordered process which requires 
several snRNPs and other splicing factors. A Prp19 complex, or so-called the 
nineteen complex (NTC), is a non-snRNP splicing complex, which interacts 
with the spliceosome immediately after the U4 dissociation, and is required for 
the activation process (Tarn et al. 1993, 1994). The complex is composed of at 
least eight proteins, i.e. Cef1, Clf1, Isy1, Ntc20, Snt309, Syf1, Syf2 and Prp19. 
Deficiency in Prp19 complex function also results in failure in spliceosome 
recycling due to impaired U4/U6 biogenesis (Chen et al. 2006).
Among Prp19 complex components, SYF1 was identified as “synthetic lethal 
with cdc forty” in a yeast genetic screen for genes that interact with CDC40/
PRP17, which is a splicing factor important for the catalytic step and plays a 
role in cell cycle progression (Ben-Yehuda et al. 2000). The Syf1 protein is an 
essential gene and highly conserved throughout the eukaryotic organisms. It 
contains fifteen copies of the tetratricopeptide repeat (TPR) motif, which is 
thought to be a scaffold domain for protein-protein interactions (for review, see 
D'Andrea and Regan 2003). Two-hybrid analysis revealed that Syf1 interacts 
with most identified Prp19 complex components, indicating that Syf1 may 
serve as a platform in maintaining the integrity of Prp19 complex (Chen et al. 
2002). 
1.5 XAB2 in human
Interestingly, Syf1 has a homolog in human known as XPA-binding protein 2 
(XAB2) which also contains TPR motifs. It has been shown that XAB2 is a 
multifunctional factor involved in pre-mRNA splicing, transcription and 
transcription-coupled repair (TCR) (Kuraoka et al. 2008). XAB2 has been 
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identified firstly by virtue of its ability to interact with Xeroderma Pigmentosum 
group A protein (XPA), a protein product of the gene that causes a disease 
with DNA-damage-processing defects (Nakatsu et al. 2000). Moreover, XAB2 
interacts with TCR-specific factors Cockayne Syndrome group A and B 
proteins (CSA and CSB) and RNAPII and is involved in transcription and TCR. 
In human cells, knockdown of XAB2 gene results in an ultraviolet 
hypersensitivity and a decrease in mRNA synthesis. XAB2 forms a hexameric 
protein complex consisting of XAB2(Syf1), hPRP19(Prp19), hISY1(Isy1), 
CCDC16, hAquarius, and PPIE. Importantly, though, it is still unclear whether 
these multiple functions of XAB2 are conserved among eukaryotes and 
whether these similar functions as TREX complex could implicate their 
interplay in gene expression. 
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Yeast Human
Functions:
Transcription elongation, nuclear 
mRNA export, DNA repair and 
genome stability
Functions:
Transcription elongation, nuclear 
mRNA export, DNA repair and 
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Functions:
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DNA repair
Figure 1.4 : Comparison of yeast and human TREX and Prp19 complex
Components of each complex and known functions are shown. Components with 
homologous proteins found in both species are written in white, otherwise in black.
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Aim of this work
In budding yeast, the conserved TREX complex, which couples transcription 
to nuclear mRNA export, is recruited to actively transcribed genes and travels 
along the genes together with RNA polymerase II (RNAPII). However, it is still 
unclear how  TREX is recruited to the transcription machinery and which 
factors mediate this interaction. Interestingly, Syf1, a component of the Prp19 
splicing complex, is homologous to human XAB2 (XPA binding protein 2), a 
multifunctional protein involved not only in splicing, but also in transcription 
and transcription-coupled DNA repair (TCR). Since XAB2 and TREX have 
several similar functions, I hypothesized that Syf1 in yeast also functions in 
transcription together with TREX. 
The aim of this work was to investigate the cellular function of Syf1 particularly 
in transcription in conjunction with TREX. Firstly, the genetic and biochemical 
interaction between SYF1 and the TREX complex should be investigated. 
Then a possible function of Syf1 in transcription should be assessed. Finally, 
the functional relationship between Syf1 and TREX in gene expression should 
be characterized.
The results of this study should provide an insight into a potential novel 
function of Syf1 and the Prp19 complex in gene expression as well as their 
functional connection with the TREX complex. This work might eventually 
provide a basis for further studies in the field of gene expression.
17
2. Results
2.1 Generation of temperature sensitive alleles of SYF1
Since XAB2, the human homolog of Syf1, has several functions similar to the 
TREX complex in human, it is interesting to investigate whether Syf1 also 
plays the same roles as XAB2 and has a functional connection with TREX in 
yeast. As SYF1 is an essential gene in yeast, one cannot simply knockout the 
gene to generate a mutant for a study. Thus, I decided to isolate conditional 
temperature sensitive (ts) alleles of SYF1 by a random mutagenesis. In Figure 
2.1, 10-fold serial dilutions of each ts strain were spotted on YPD, a complete 
medium for yeast growth, and incubated at 30ºC, 33ºC and 37ºC. Cells 
carrying one of the five ts alleles grew normally as wild-type cells at the 
permissive temperature, 30ºC, but were lethal at the restrictive temperature, 
37ºC. Interestingly, all alleles grew differently at the intermediate temperature, 
33ºC.
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Figure 2.1: Temperature sensitive alleles of SYF1 
Ten-fold serial dilutions of yeast cells expressing wild-type SYF1 or one of five ts 
alleles of SYF1 were spotted onto YPD plates and incubated for 2 days at 30°C 
(permissive temperature), 33°C (intermediate temperature), or 37°C (restrictive 
temperature), respectively.
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Syf1       1 MSAYIAMKGVITNVDENIRNDEDVAFEYEIQKTPQNILTWKRYIEYWKEEGRTDKQIRWLYERFCSQFVTDTSIWEDYIRWESTKEVVET 
syf1-1     1 MSAYIAMKGVITNVDENIRNDEDVAFEYEIQKTPQNILTGKRYIEYWKEEGRTDKQIRWLYERFCSQFVTDTSIWEDYIRWESTKEVVET 
syf1-2     1 MSAYIAMKGVITNVDENIRNDEDVAFEYEIQKTPQNILTWKRYIEYWKEEGRTDKQIRWLYERFCSQFATDTSIWEDYIRWESTKEVVET 
syf1-15    1 MSAYIAMKGVITNVDENIRNDEDVAFVYEIQKTPQNILTWKRYIEYWKEEGRTDKQIRWLYERFCSQFVTDTSIWEDYIRWESTKEVVET 
syf1-34    1 MSAYIAMKGVITNVDENIRNDEDVAFEYEIQKTPQNILTWKRYIEYWKEEGRTDKQIRWLYERFCSQFVTDTSIWEDYIRWESTKEVVET 
syf1-37    1 MSAYFAMKGVITNVDENIRNDEDVAFEYEIQKTPQNILTWKRYIEYWKEEGRTDKQIRWLYERFCSQFVTDTSIWEDYIRWESTKEVVET 
 
 
Syf1      91 SRIFWLFQRCLKSCVRDCDRICLSYLELAIEQYDLAMIRHALASSLMKMEREMHRKVWDPVIKFVEEKVLPLTQLDSTQEDEEESTDEAE 
syf1-1    91 SRIFWLFQRCLKSCVRDCDRICLSYLELAIEQYDLAMIRHALASSLMKMEREMHRKVWDPVIKFVEEKVLPLTQLDSTQEDEEESTDEAE 
syf1-2    91 SRIFWLFQRCLKSCVRDCDRICLSYLELAIEQCDLAMIRHALASSLMKMEREMHRKVWDPVIKFVEEKVLPLTQLDSTQEDEEESTDEAE 
syf1-15   91 SRIFWLFQRCLKSCVRDCDRICLSYLELAIEQYDLAMIRHALASSLMKMEREMHRKVWDPVIKFVEEKVLPLTQLDSTQEDEEESTDEAE 
syf1-34   91 SRIFWLFQRCLKSCVRDCDRICLSYLELAIEQYDLAMIRHALASSLMKMEREMHRKVWDPVIKFVEEKVLPLTQLDSTQEDEEESTDEAE 
syf1-37   91 SRIFWLFQRCLKSCVRDCDRICLSYLELAIEQYDLAMIGHALASSLMKMEREMHRKVWDPVIKFVEEKVLPLTQLDSTQEDEEESTDEAE 
 
 
Syf1     181 LINVLLVKGFTKGGFISEEISENGSRGDIWSSHILERYLKVAPQQKRNESLATLALTRDNITIKSVYEKYLPQDENSGKYLPSSELPFEL 
syf1-1   181 LINVLLVKGFTKGGFISEEISENGSRGDIWSSHILERYLKVAPQQKRNESLATLALTRDNITIKSVYEKYLPQDENSGKYLPSSELPFEL 
syf1-2   181 LINVLLVKGFTKGGFISEEISENGSRGDIWSSHILERYLKVAPQQKRNESLATLALTRDNITIKSVYEKYLPQDENSGKYLPSSELPFEL 
syf1-15  181 LINVLLVKGFTKGGFISEEISENGSRGDIWSSHILERYLKVAPQQKRNESLATLALTRDNITIKSVYEKYLPQDENSGKYLPSSELPFEL 
syf1-34  181 LINVLLVKGFTKGGFISEEISENGSRGDIWSSHILERYLKVAPQQKRNESLATLALTRDNITIKSVYEKYLPQDENSGKYLPSSELPFEL 
syf1-37  181 LINVLLVKGFTKGGFISEEISENGSRGDIWSSHILERYLKVAPQQKRNESLATLALTRDNITIKSVYEKYLPQDENSGKYLPSSELPFEL 
 
                       
Syf1     271 NFNYLASLEKLGLDNQYEEFMRQMNGIYPDKWLFLILSLAKYYISRGRLDSCGDLLKKSLQQTLRYSDFDRIYNFYLLFEQECSQFILGK 
syf1-1   271 NFNYLASLEKLGLDNQYEEFMRQMNGIYPDKWLFLILSLAKYYISRGGLDSCGDLLKKSLQQTLRYSDFDRIYNFYLLFEQECSQFILGK 
syf1-2   271 NFNYLASLEKLGLDNQYEEFMRQMNGIYPDKWLFLILSLAKYYISRGRLDSCGDLLKKSLQQTLRYSDFDRIYNFYLLFEQECSQFILGK 
syf1-15  271 NFNYLASLEKLGLDNQYEEFMRQMNGIYPDKWLFLILSLAKYYISRGRLDSCGDLLKKSLQQTLRYSDFDRIYNFYLLFEQECSQFILGK 
syf1-34  271 NFNYLASLEKLGLDNQYEEFMRQMNGIYPDKWLFLILSLAKYYISRGRLDSCGDLLKKSLQQTLRYSDFDRIYNFYLLFEQECSQFILGK 
syf1-37  271 NFNYLASLEKLGLDNQYEEFMRQMNGIYPDKWLFLILSLAKYYISRGRLDSCGDLLKKSLQQTLRYSDFDRIYNFYLLFEQECSQFILGK 
 
                                  
Syf1     361 LKENDSKFFNQKDWTEKLQAHMATFESLINLYDIYLNDVALRQDSNLVETWMKRVSLQKSAAEKCNVYSEAILKIDPRKVGTPGSFGRLW 
syf1-1   361 LKENDSNFFNQKDWTEKLQAHMATFESLINLYDIYLNDVALRQDSNLVGTWMKRVSLQKSAAEKCNVYSEAILKIDPRKVGTPGSFGRLW 
syf1-2   361 LKENDSKFFNQKDWTEKLQAHMATFESLINLYDIYLNDVALRQDSNLVETWMKRVSLQKSAAEKCNVYSEAILKIDPRKVGTPGSFGRLW 
syf1-15  361 LKENDSKFFNQKDWTEKLQAHMATFESLINLYDIYLNDVALRQDSNLVETWMKRASLQKSAAEKCNVYSEAILKIDPRKVGTPGSFGRLW 
syf1-34  361 LKENDSKFFNQKDWTEKLQAHMATFESLINLYDIYLNDVALRQDSNLVETWMKRVSLQKSAAEKCNVYSEAILKIDPRKVGTPGSFGRLW 
syf1-37  361 LKENDSKFFNQKDWTEKLQAHMATFESLINLYDIYLNDVALRQDSNLVETWMKRVSLQKSAAEKCNVYSEAILKIDPRKVGTPGSFGRLW 
 
              
Syf1     451 CSYGDLYWRSNAISTARELWTQSLKVPYPYIEDLEEIYLNWADRELDKEGVERAFSILEDALHVPTNPEILLEKYKNGHRKIPAQTVLFN 
syf1-1   451 CSYGDLYWRSNAISTARELWTQSLKVPYPYIEDLEEIYLNWADRELDKEGVERAFSILEDALHVPTNPEILLEKYKNGHRKIPAQTVLFN 
syf1-2   451 CSYGDLYWRSNAISTARELWTQSLKVPYPYIEDLEEIYLNWADRELDKEGVERAFSILEDALHVPTNPEILLEKYKNGHRKIPAQTVLFN 
syf1-15  451 CSYGDLYWRSNAISTARELWTQSLKVPYPYIEDLEEIYLNWADRELDKEGVERAFSILEDALHVPTNPEILLEKYKNGHRKIPAQTVLFN 
syf1-34  451 CSYGDLYWRSNAISTARELWTQSLKVPYPYIEDLEEIYLNWADRELDKEGVERAFSILEDALHVPTNPEILLEKYKNGHRKIPAQTVLFN 
syf1-37  451 CSCGDLYWRSNAISTARELWTQSLKVPYPYIEDLEEIYLNWADRELDKEGVERAFSILEDALHVPTNPEILLEKYKNGHRKIPAQTVLFN 
 
                    
Syf1     541 SLRIWSKYIDYLEAYCPKDANSSDKIFNKTKMAYNTVIDLRLITPAMAENFALFLQNHYEVMESFQVYEKTIPLFPPEIQYELWIEYLEV 
syf1-1   541 SLRVWSKYIDYLEAYCPKDANSSDKIFNKTKMAYNTVIDLRLITPAMAENFALFLQNHYEVMESFQVYEKTIPLFPPEIQYELWIEYLEV 
syf1-2   541 SLRIWSKYIDYLEAYCPKDANSSDKIFNKTKMAYNTVIDLRLITPAMAENFALFLPNHYEVMESFQVYEKTIPLFPPEIQYELWIEYLEV 
syf1-15  541 SLRIWSKYIDYLEAYCPKDANSSDKIFNKPKMAYNTVIDLRLITPAMAENFALFLQNHYEVMESFQVYEKTIPLLPPEIQYELWIEYLEV 
syf1-34  541 SLRIWSKYIDYLEAYCPKDANSSDKIFNKTKMAYNTVIDLRLITPAMAENFALFLQNHYEVMESFQVYEKTIPLFPPEIQYELWIEYLEV 
syf1-37  541 SLRIWSKYIDYLEAYCPKDANSSDKIFNKTKMAYNTVIDLRLITPAMAENFALFLQNHYEVMESFQVYEKTIPLFPPEIQYELWIEYLEV 
 
 
Syf1     631 ATSHQLSSLSPEHIRFLFEKALKNLCSNGIDCKTIFIAYSVFEERISGLISKSIEILRRGAVIGTVSVSTHLESRLQLWRMCISKAESTL 
syf1-1   631 ATSHQLSSLSPEHIRFLFEKALKNLCSNGIDCKTIFIAYSVFEERISGLISKSIEILRRGAVIGTVSVSTHLESRLQLWRMCISKAESTL 
syf1-2   631 ATSHQLSSLSPEHIRFLFEKALKNLCSNGIDCKTIFIAYSVFEERISGLISKSIEILRRGAVIGTVSVSTHLESRLQLWRMCISKAESTL 
syf1-15  631 ATSHQLSSLSPEHIRFLFEKALKNLCSNGIDCKTIFIAYSVFEERISGLISKSIEILRRGAVIGTVSVSTHLESRLQLWRMCISKAESTL 
syf1-34  631 ATSHQLSSLSPEHIRFLFEKALKNLCSNGIDCKTIFIAYSVFEERISGLISKSIEILRRGAVIGTVSVSTHLESRLQLWRMCISKAESTL 
syf1-37  631 ATSHQLSSLSPEHIRFLFEKALKNLCSMV------------------------------------------------------------- 
 
              
Syf1     721 GPSVTRELYQECIQILPNSKAVEFVIKFSDFESSIGETIRAREILAYGAKLLPPSRNTELWDSFEIFELKHGDKETYKDMLKMKKVLESN 
syf1-1   721 GPSVTRELYQECIQILPNSKAVEFVIKFSDFESSIGETIRAREILAYGAKLLPPSRNTELWDSFEIFELKHGDKETYKDMLKMKKVLESN 
syf1-2   721 GPSVTRELYQECIQILPNSKAVEFVIKFSDFGSSIGETIRAREILAYGAKLLPPSRNTELWDSFEIFELKHGDKETYKDMLKMKKVLESN 
syf1-15  721 GPSVTRELYQECIQILPNSKAVEFVIKFSDFESSIGETIRAREILAYGAKLLPPSRNTELWDSFEIFELKHGDKETYKDMLKMKKVLESN 
syf1-34  721 GPSVTRELFQECIQILPNSKAVEFVIKFSDFESSIGETIRAREILAYGAKLLPPSRNTELWDSFEIFELKHGDKETYKDMLKMKKVLESN 
syf1-37  721 ------------------------------------------------------------------------------------------ 
 
 
Syf1     811 MLIDSASVSHEEGNINFVAAATSHAPNSHTLTQSTSSYSINPDEIELDI 
syf1-1   811 MLIDSASVSHEEGNINFVAAATSHAPNSHTLTQSTSSYSINPDEIELDI 
syf1-2   811 MLIDSASVSHEEGNINFVAAATSHAPNSHTLTQSTSSYSINPDEIELDI 
syf1-15  811 MLIDSASVSHEEGNINFVAAATSHAPNSHTLTQSTSSYSINPDEIELDI 
syf1-34  811 MLIDSASVSHEEGNINFVAAATSHAPNSHTLTQSTSSYSINPDEIELDI 
syf1-37  811 ------------------------------------------------- 
 
 
Figure 2.2: An amino acid sequence alignment of Syf1 and its ts mutants 
Darkened areas show the residue identity and shaded areas represent mutations. 
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Then, the plasmids carrying the putative ts alleles were rescued and 
sequenced in order to identify the mutations. Amino acid alignment of all syf1 
ts alleles is shown in Figure 2.2.
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Figure 2.3: Growth curves for SYF1 and its ts alleles
Cells were grown under permissive, 30ºC (A), and restrictive conditions, 37ºC (B).
In order to acquire growth information of those strains, growth curves were 
determined at 30ºC and 37ºC as shown in Figure 2.3. Though some mutants 
A
B
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grow  slightly slower than wild-type cells, all strains could duplicate and grow 
logarithmically at the permissive temperature, 30ºC. However, after growth at 
the non-permissive temperature, 37ºC, for about three hours the ts mutants 
stop growing. 
2.2 Genetic interaction between SYF1 and the THO complex
2.2.1 The principle of synthetic lethality
For the first indication of a functional overlap of Syf1 and the TREX complex, 
the ts alleles of SYF1 and the deletion mutants of the THO complex were 
used to test for a genetic interaction. Alleles having a synthetic lethal 
relationship, one of several approaches to assess genetic interaction, can 
often, but not always, be explained based on the functions of their proteins. 
For instance, they might be unambiguously redundant with regard to an 
essential function, be two subunits of an essential multi-protein complex, be 
two interconnected factors in an important linear pathway, or involve in parallel 
pathways that are together essential for live. By exploring a synthetic lethal 
relationship, it may help address questions about how cellular processes work 
when the protein products expressed by two different genes have an effect 
together but not separately. 
Generally, two alleles are synthetically lethal when the combination of two 
viable mutations in these genes leads to cell death. As one approach to 
address the synthetic lethality between two genes, X and Y, a double 
knockout strain of the two genes of interest that carries the wild-type copies of 
both proteins on URA3 plasmids (double shuffle strain) is generated. These 
strains are transformed with combinations of plasmids carrying either wild-type 
copy of gene X or Y, or mutated x or y. The wild-type copies of both genes 
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encoded by the URA3 plasmids are then removed by streaking the cells onto 
plates containing 5-fluoroorotic acid (5-FOA). If cells carrying both mutated 
genes are lethal on 5-FOA plate, the mutant alleles are synthetically lethal 
(Figure 2.4). 
Figure 2.4: Principle of synthetic lethality
Two genes are synthetic lethal only when their simultaneous mutation results in 
cellular or organismal death, i.e., mutation of either gene X or gene Y does not affect 
viability whereas mutation of both genes at the same time is lethal.
2.2.2 SYF1 is synthetic lethal with HPR1 and MFT1
As XAB2, a human homolog of the yeast SYF1, has several functions similar 
to the TREX complex in higher eukaryotes, I hypothesized that SYF1 in yeast 
plays an overlapping role with the TREX complex. To test this hypothesis, I 
assessed the genetic relationship between SYF1 and the THO complex, a 
subcomplex of the TREX complex, by synthetic lethality. Double shuffle stains 
of SYF1 and HPR1 or MFT1 were generated. They were transformed with 
SYF1 or one of the syf1 ts alleles and HPR1, MFT1 or an empty plasmid. 
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Transformants were streaked onto plates containing 5-FOA and their growth 
was analyzed after incubation at 30ºC for 5 days. 
As shown in Figure 2.5, combination of syf1-37 and ∆hpr1 or ∆mft1 leads cells 
to lethality, indicating the synthetic lethal relationship between SYF1 with 
HPR1 and MFT1. Since, SYF1 is not in the same complex with THO, SYF1 
might be functionally redundant with respect to the THO complex, or be in the 
same linear pathway with THO, or involve in parallel pathways with THO that 
are together crucial for cells. 
Figure 2.5 : SYF1 genetically interacts with the THO complex components, 
HPR1 and MFT1
SYF1 HPR1 and SYF1 MFT1 double shuffle strains were transformed with an empty 
plasmid or plasmids encoding wild-type HPR1 or MFT1, respectively, and a plasmid 
encoding wild-type SYF1 or syf1-37. Synthetic lethality was assessed by restreaking 
the transformants on plates containing 5-FOA.
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Remarkably, among five syf1-ts alleles, syf1-37 is the only allele that 
genetically interacts with the THO complex while the other ts alleles do not as 
shown in Table 1.
∆hpr1 ∆mft1
SYF1 - -
syf1-1 - -
syf1-2 ss ss
syf1-15 - -
syf1-34 - -
syf1-37 sl sl
Table 1: SYF1 genetically interacts with HPR1 and MFT1 in an allele-specific 
manner
SYF1 HPR1 and SYF1 MFT1 shuffle strains were transformed with an empty 
plasmid or plasmids encoding wild-type HPR1 or MFT1, respectively, and a plasmid 
encoding wild-type SYF1 or one of the five syf1-ts alleles. An sl interaction was 
assessed by restreaking the respective transformants on 5-FOA containing plates. sl: 
synthetic lethal; ss: synthetic sick; -: no genetic interaction.
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2.3 Physical interaction between Syf1 and the THO complex
Since SYF1 genetically interacts with the THO complex, it is possible that they 
also interact biochemically with each other and function together in the cells. 
To test this, I performed a coimmunoprecipitation assay using protein extracts 
from Syf1-hemagglutinin(HA)- and Hpr1-tandem-affinity-purification(TAP)-
tagged cells. Hpr1-TAP was immunoprecipitated by IgG sepharose, and the 
immunoprecipitates were probed by α-HA. Syf1-HA could be coimmuno-
precipitated with Hpr1, whereas no signal was detected in the control (Figure 
2.6). 
A.
!Npl3
!HA
RNase A+-- +--
B.
Syf1-HA+++ +++
Hpr1-TAP++- ++-
GENESDEV/2011/162727_Fig1_Chanarat
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Hpr1-CBP
Mft1+Sub2
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120
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200
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SYF1   -  -
syf1-1   -  -
syf1-2  ss ss
syf1-15   -  -
syf1-34   -  -
syf1-37  sl sl
"hpr1 "mft1
Figure 2.6: Syf1 interacts with TREX in an RNA-independent manner 
The TREX complex was purified using TAP-tagged Hpr1 and copurification of HA-
tagged Syf1 assessed by western blotting with α-HA antibody (α-HA). To assess 
whether the interaction between TREX and Syf1 is mediated by RNA, cell extract 
was treated with RNase A prior to purification. Npl3, an SR-protein involved in 
mRNA export that interacts with TREX in an RNA-dependent manner, served as 
positive control for the RNase treatment (α-Npl3). IN: input, IP: immunoprecipitation, 
Coomassie: Tobacco-etch-virus protease (TEV) eluate of the TAP purification.
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Since Syf1 is a component of the splicing machinery and THO is able to 
interact with RNA, I assessed whether this interaction is mediated by RNA. 
After RNase treatment, Syf1-HA was still coimmunoprecipitated with Hpr1 
indicating that Syf1 binds the THO complex in an RNA-independent manner 
(Figure 2.6).
Taken together Syf1 interacts with TREX both genetically and physically.
2.4 Deletion of the C-terminal domain of Syf1 causes 6-
azauracil sensitivity and synthetic lethal with ∆hpr1 or ∆mft1
The genetic interaction between SYF1 and THO indicates that Syf1 might 
have overlapping functions with the THO/TREX complex, namely transcription 
and/or mRNA export. To assess whether SYF1 also plays a role in 
transcription, I tested syf1-ts cells for sensitivity to 6-azauracil (6-AU), a drug 
that impairs transcription elongation by reducing GTP/UTP from intracellular 
nucleotide pools. Interestingly, among the five syf1-ts alleles, syf1-37, the only 
allele that genetically interacts with THO, causes 6-AU sensitivity (Figure 2.7). 
This result suggests for the first time that Syf1 might play a role in transcription 
elongation and that the genetic interaction between SYF1 and THO might be 
caused by their overlapping function in transcription elongation.
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Figure 2.7: The syf1-37 ts mutant is sensitive to 6-AU 
10-fold serial dilutions of yeast cells expressing wild-type SYF1 or one of five 
different ts alleles of SYF1 and containing pRS316 were spotted onto SDC(-ura) 
plates containing solvent or 50 µg/ml 6-AU and incubated for 2 days at 30°C.
Interestingly, the syf1-37 ts allele is the only mutant that encodes a C-terminal-
truncated protein (Figure 2.2). To confirm whether the mutant does not 
generate a full-length protein due to a read-through of the nonsense codon 
during translation as previously shown for some proteins, different dilutions of 
the whole cell extracts of TAP-syf1-37 (1-100x) and of TAP-SYF1 cells (100x) 
were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) and the amount of Syf1 was assessed by western blotting using 
an antibody recognizing the protein A tag. As shown in Figure 2.8, no full-
length Syf1 could be detected as a result of frame-shifting during the 
translation of the syf1-37 allele, i.e. if any, the product of the read-through of 
the nonsense codon is less than 1% of the truncated protein.
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Figure 2.8: The syf1-37 ts mutant is a C-terminal truncated protein
No full-length Syf1 can be detected as a consequence of frame-shifting during 
translation of the syf1-37 allele. Different dilutions of whole cell extracts of TAP-
syf1-37 (1 to 100x) and of TAP-SYF1 cells (100x) were separated by SDS-PAGE and 
the amount of TAP-syf1-37 and TAP-Syf1 assessed by  western blotting using an 
antibody recognizing protein A. Frame-shifting during translation of the syf1-37 allele 
to produce full-length Syf1 is, if any, less than 1%.
Syf1 is mainly composed of 15 tetratricopeptide repeat (TPR) motifs. TPR 
motif exhibits a high degree of sequence diversity, but structural comparison 
reveals a highly conserved three dimensional structure, which consists of two 
anti-parallel alpha helices separated by a turn. The motif has been found in 
many organisms ranging from bacteria to humans and is thought to be a 
scaffold domain for protein complex assembly. Since syf1-37 lacks the four 
most C-terminal TPR motifs, I asked whether this truncation causes SYF1 to 
interact genetically with HPR1 and MFT1. To answer this question, I gradually 
truncated the C-terminal part of Syf1 proteins and tested for the synthetic 
lethality of those different mutants with ∆hpr1 or ∆mft1 (Figure 2.9). Deletion of 
the C-terminal unstructured region of Syf1 (syf1-∆C), the last (15th) and the 
last two (14th and 15th) TPR motifs (syf1-∆15 and syf1-∆14, respectively) were 
not synthetic lethal with both ∆hpr1 and ∆mft1. When I deleted one more TPR 
motif (syf1-∆13), it became synthetic lethal with ∆hpr1 and ∆mft1. Additional 
deletion of the next (12th) TPR motif (syf1-∆12) also caused the synthetic 
lethality. Note that this syf1-∆12 is 20 amino acids longer than the syf1-37. 
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Thus, the deletion of the C-terminal part of Syf1 is indeed responsible for the 
genetic interaction with the THO complex. 
           
SYF1
syf1-1
syf1-2
syf1-15
syf1-34
syf1-37
+ solvent + 6AU
A.
B.
8591
659
1
1
7551
719
synthetic lethal wih 
!hpr1 and !mft1
no
no
yes
yes
I II III IV V VI VII VIII IX X XI XII XIII XIV XV
821
794
679
Syf1
syf1-37
syf1-!14
syf1-!13
syf1-!C
syf1-!15
syf1-!12
1
1
1
no
no
yes
TPR motif
GENESDEV/2011/162727_Fig2_Chanarat
SYF1
syf1-1
syf1-2
syf1-15
syf1-34
syf1-37
+ solvent + 6AU
A.
B.
8591
659
1
1
7551
719
synthetic lethal wih 
!hpr1 and !mft1
no
no
yes
I II III IV V VI VII VIII IX X XI XII XIII XIV XV
821
794
679
Syf1
syf1-37
syf1-!14
syf1-!13
syf1-!C
syf1-!15
syf1-!12
1
1
1
no
no
TPR motif
GENESDEV/2011/162727_Fig2_Chanarat
Figure 2.9: The C-terminus of Syf1 is important for the genetic interaction of 
SYF1 with HPR1 and MFT1 
Schematic diagram showing the domain structure of Syf1 with each TPR motif 
indicated by a zigzag. Deletion of the three most C-terminal TPR motifs (syf1-∆13) 
leads to synthetic lethality with ∆hpr1 and ∆mft1.
2.5 Syf1 functions in transcription
2.5.1 Syf1 and Prp19 complex are recruited to transcription 
machinery in vivo
Genetic interaction with THO components, 6-AU sensitivity of a syf1 mutant 
and transcription activity of the human homolog XAB2 suggest that Syf1 might 
also play a role in transcription in yeast. Thus, I hypothesized that if Syf1 is a 
general transcription factor, it should be present at the transcription machinery 
not only on intron-containing genes where splicing occurs, but also on 
intronless genes. To assess this, I performed chromatin immunoprecipitation 
29
(ChIP) assays using a SYF1-TAP strain and assessed the recruitment of the 
protein to four intronless genes (ADH1, PGK1, PMA1, and PDR5; Figure 2.10) 
and two intron-containing genes (ACT1 and DBP2; Figure 2.10). Occupancy 
on these six genes was calculated as the enrichment of Syf1 at the respective 
gene relative to a non-transcribed region (NTR) serving as a negative control. 
Strikingly, Syf1 is specifically recruited to all of these six genes, but not to the 
NTR (Figure 2.11). Since Syf1 is recruited to intronless genes, it might have a 
general function in transcription. 
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Figure 2.10: Schematic diagram of the ADH1, PGK1, PMA1, PDR5, ACT1, and 
DBP2 genes
The open reading frames (ORFs) are represented by  a solid and the introns by a 
hatched line. Bars above the genes show the positions of the primer pairs used for 
the ChIP analysis. 
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Figure 2.11: Syf1 is recruited to transcribed genes 
The occupancy of Syf1 at the intronless ADH1, PGK1, PDR5, and PMA1 and the 
intron-containing ACT1 and DBP2 genes was calculated as the enrichment of Syf1 
at the respective gene relative to its presence at the NTR. The occupancy at the 
NTR was set to 1 as indicated by a dashed line. 
Next, I asked whether Syf1 alone or the whole Prp19 complex is recruited to 
the genes. To do this, I assessed the occupancy of two other Prp19 complex 
components, namely Prp19 and Ntc20, to the six genes shown above. Prp19 
(Figure 2.12) and Ntc20 (Figure 2.13) were also present at these genes 
suggesting that the whole Prp19 complex is recruited to transcribed genes.
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Figure 2.12: Prp19 is recruited to transcribed genes 
Experiment as in Figure 2.11, except the occupancy of Prp19 was assessed.
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Figure 2.13: Ntc20 is recruited to transcribed genes 
Experiment as in Figure 2.11, except the occupancy of Ntc20 was assessed.
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2.5.2. Recruitment of Syf1 to transcribed genes is  transcription 
dependent
Next, I asked whether the recruitment of Syf1 to transcribed genes is 
dependent on an active transcription. To test this, I assessed the occupancy of 
Syf1 at the inducible GAL1 gene. The GAL1 gene is not expressed when cells 
are grown in raffinose-containing medium and is induced when cells are 
grown in galactose-containing medium. The recruitment of Syf1 to the GAL1 
gene was observed only when the gene is induced, but was not in the non-
induced condition (Figure 2.14). This indicates that Syf1 recruitment to the 
transcription machinery is transcription dependent.
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Figure 2.14: Recruitment of Syf1 to a gene is transcription dependent
Occupancy of Syf1 to the GAL1 gene under non-induced (cells grown in glucose-
containing medium, dark grey  bars), which was set to 1, and induced conditions 
(cells grown in galactose-containing medium, light grey bars). Primer pairs amplify 
the 5ʼ and 3ʼ region of GAL1 as indicated in the upper panel.
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2.5.3. Functional Syf1 is  necessary for effective transcription in 
vivo
As Syf1 is physically present at transcribing genes in a transcription-
dependent manner, it is very likely that Syf1 plays a role in transcription and 
affects transcription activity in vivo. To assess this, I performed an in vivo 
transcription assay. Among the SYF1 truncation mutants, syf1-∆13 is the 
longest allele and synthetic lethal with ∆hpr1 and ∆mft1. However, because 
syf1-∆13 cells grow more slowly than the syf1-37 ts mutant, I chose the latter 
mutant for performing further experiments in order to avoid unspecific effects 
due to slow growth (see Figure 2.15).
Figure 2.15: Growth curves of SYF1, syf1-37, and syf1-Δ13 cells at 30°C
Growth curves of SYF1, syf1-37, and syf1-Δ13 cells in YPD at 30°C by measuring 
optical density at 600 nm.
In the transcription assay, I used two reporter constructs: ACT1 as an intron-
containing gene and GAL10 as an intronless gene, both of which were 
controlled by the regulatable GAL10 promoter (GAL10::ACT1 and 
GAL10::GAL10, respectively.) Wild-type and mutant cells were grown in 
raffinose-containing medium at permissive temperature. Then, galactose was 
added and cells harvested at 0, 15, 30 and 60 minutes (min) after induction. 
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Next, RNA was extracted and the amount of the ACT1 and GAL10 mRNAs 
quantified. As shown in Figure 2.16, the amount of both ACT1 and GAL10 
mRNAs were reduced in the syf1-37 mutant compared to the wild-type cells, 
indicating that in this mutant mRNA synthesis of both intron-containing and 
intronless genes are decreased due to the mutation of the SYF1 gene.
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Figure 2.16: Functional Syf1 is necessary for efficient transcription in vivo
GAL10::ACT1 and GAL10::GAL10 were used as reporters for an intron-containing 
and an intronless gene, respectively. The level of ACT1 (solid) and GAL10 (dotted) 
mRNAs of cells grown for 0, 15, 30, and 60 min after galactose induction at the 
permissive temperature (30°C) was assessed by primer extension and normalized to 
the amount of SCR1 RNA, an RNAPIII transcript.
Since Syf1 is known as a splicing factor, I asked whether this decreased 
transcription activity is related to splicing activity and/or a secondary effect of 
defective splicing. By using the same GAL10::ACT1 reporter construct, I 
quantified the ratio of the amount of spliced and unspliced mRNAs and 
subsequently calculated the splicing efficiency. Expression of the 
GAL10::ACT1 reporter was induced for 1 hour and the amount of spliced and 
unspliced ACT1 mRNAs assessed (Figure 2.17). As expected for a ts mutant 
of a splicing factor, unspliced transcripts accumulated in the syf1-37 strain at 
the restrictive temperature. More importantly, the syf1-37 mutant did not show 
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a splicing defect at the permissive temperature, indicating that the decrease in 
ACT1 mRNA level in the syf1-37 strain is most likely not a secondary effect of 
defective splicing.
Figure 2.17: Splicing is not affected in syf1-37 cells
The GAL10::ACT1 reporter construct was induced for 1 hour with galactose in SYF1 
and syf1-37 cells, which were grown at the permissive temperature (30°C) or shifted 
for 1 h to the restrictive temperature (37°C). The amount of spliced and unspliced 
ACT1 RNA was assessed by  PCR. The splicing efficiency was calculated as the ratio 
of unspliced versus total ACT1 RNA.
Taken together, SYF1 is necessary for effective transcription in vivo and the 
function in transcription is independent of its splicing activity.
36
2.5.4 Functional Syf1 is necessary for effective transcription in vitro
As most cellular processes in vivo are highly complex and intimately linked, 
the decreased mRNA synthesis in syf1-37 ts strain could also be a secondary 
effect of any step in gene expression that is impaired in the cells. In order to 
clarify whether Syf1 is directly involved in transcription, I decided to make use 
of an in vitro transcription assay. 
I performed a plasmid-based in vitro transcription assay with either a HIS4 or 
a SER3 promoter (Koschubs et al. 2009) and prepared nuclear extracts from 
the SYF1 and the syf1-37 cells. At permissive temperature (18°C), the syf1-37 
nuclear extract had slightly lower transcriptional activity than the wild-type 
extract (Figure 2.18, lane 1-2), which could be due to the mutation or to 
variations in the nuclear extract preparation. Importantly, though, when the 
temperature during the transcription reaction was raised to the restrictive 
temperature (30°C), the activity of the syf1-37 nuclear extract decreased 
significantly compared to the wild-type extract (Figure 2.18). 
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Figure 2.18: Functional Syf1 is necessary for efficient transcription in vitro
The transcription activity of nuclear extracts from SYF1 and syf1-37 cells was 
assessed at 18°C (permissive temperature, lanes 1 and 2) and 30°C (restrictive 
temperature, lanes 3 and 7) by an in vitro transcription assay using a template 
containing either a HIS4 or a SER3 promoter. Add-back of 50, 125 or 250 ng of 
Prp19 complex purified from S. cerevisiae rescued the impaired transcription activity 
of the syf1-37 extract at the restrictive temperature (lanes 7-10). 
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Figure 2.19: The purified Prp19 complex used for the add-back in the in vitro 
transcription experiment does not contain RNAPII 
250 ng Prp19 complex were separated by SDS-PAGE and stained with Coomassie 
(left panel) or assessed for the presence of Rpb1, the largest subunit of RNAPII, by 
western blotting with an antibody recognizing the N-terminus of Rpb1 (yN-18, right 
panel). WCE: whole cell extract.
To assess further whether this reduction is indeed due to an inactive Syf1 
protein in syf1-37 nuclear extract but not the other proteins inactivated during 
the restrictive temperature, I performed an add-back experiment with the 
Prp19 complex purified from yeast. Strikingly, the addition of the Prp19 
complex rescued the transcriptional activity of the syf1-37 extract in a dose-
dependent manner (Figure 2.18, lane 7-10). Because RNAPII was not found 
in the purified Prp19 complex added back to the extract assessed by western 
blotting (Figure 2.19) and the addition of the purified protein could not increase 
the transcriptional activity of the wild-type extract (Figure 2.18, lane 3-6), the 
activity rescued in the syf1-37 (Figure 2.18, lane 7-10) was not simply caused 
by adding more active transcription machinery or other stimulating 
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transcription factor copurifying with the Prp19 complex. Taken together, this 
result indicates that the decreased activity in the syf1-37 extract is due to 
impaired function of the syf1-37 ts protein and that the Syf1/Prp19 complex is 
indeed necessary for transcriptional activity in vitro. In summary, functional 
Syf1 is necessary for effective transcription in vitro.
2.5.5 Syf1 is necessary for full RNAPII processivity
As syf1-37 cells are sensitive to 6-AU, a transcription elongation inhibitor, and 
the fact that the THO/TREX complex plays a role in transcription elongation, 
Syf1 is most likely also involved in the elongation phase of transcription. In 
principle, a decreased transcriptional activity during elongation can be caused 
by a reduction in the rate of transcription, namely the speed of elongating 
RNAPII, or by a decrease in the processivity of RNAPII, namely the capability 
of transcribing RNAPII to travel the entire length of the gene. Interestingly, it 
has been shown that deletion of the THO complex components reduces 
RNAPII processivity (Mason and Struhl 2005). It is possible that the Syf1/
Prp19 complex functions in the same way as the THO complex and plays a 
role in RNAPII processivity. To clarify this, I measured RNAPII processivity by 
quantifying the level of RNAPII associated at five positions along the 8-kb-long 
YLR454 gene under the control of GAL1 promoter in cells grown in galactose-
containing medium.
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Figure 2.20: RNAPII processivity is decreased in ∆hpr1 and syf1-37 cells
(A) Schematic diagram of the GAL1::YLR454 reporter gene used for analyzing 
RNAPII processivity in wild-type, ∆hpr1, SYF1, and syf1-37 cells grown at 
permissive temperature, 30°C. Positions of primer pairs used for the ChIP analysis 
are indicated above the gene. 
(B) Relative RNAPII occupancy within the YLR454 gene in wile-type, ∆hpr1, SYF1, 
and syf1-37 cells grown in the medium containing galactose. The occupancy in wild-
type cells at each position was set to 1. 
(C) Relative RNAPII occupancy as in (B) in the presence of 50 µg/ml 6-AU.
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As shown previously, deletion of HPR1 caused a reduction in RNAPII 
processivity and addition of 6-AU increased the defect. Processivity of RNAPII 
was not affected by the syf1-37 mutation in the absence of 6-AU. Importantly, 
in the presence of 6-AU, RNAPII processivity was reduced in syf1-37 cells 
indicating a transcription elongation defect in this mutant (Figure 2.20). Thus, 
Syf1 plays a role in transcription elongation and is required for efficient 
RNAPII processivity when transcription elongation is impaired by 6-AU.
2.6 The C-terminus of Syf1 is required for recruitment of the 
Prp19 complex to transcribed genes and for the interaction of 
the Prp19 complex with RNAPII 
So far, I have identified the syf1-37 allele which has a decreased transcription 
activity and lacks the four most C-terminal TPR motifs, known as scaffold 
domains for protein-protein interactions. Thus, it might be possible that by the 
lack of its C-terminal TPR motifs, Syf1 does not interact with some other 
proteins necessary for efficient transcription activity or is not recruited to the 
RNAPII transcription machinery and, as a result, transcription efficiency is 
reduced. To test this, I assessed recruitment of syf1-37 to three representative 
genes, namely ADH1, PMA1 and DBP2, by the ChIP assay. While RNAPII 
recruitment to genes in syf1-37 cells is comparable to its recruitment in SYF1 
cells, the occupancy of syf1-37 relative to RNAPII is significantly reduced to 
approximately 50% compared to the wild-type cells, indicating that syf1-37 
could not be recruited efficiently to transcription machinery in vivo (Figure 
2.21). 
Since Syf1 is a component of the Prp19 complex, I asked whether not only 
Syf1 recruitment but also recruitment of the whole Prp19 complex is reduced 
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in syf1-37 cells. Therefore, I assessed the occupancy of two other Prp19 
complex components, namely Prp19 and Ntc20, in SYF1 and syf1-37 cells. In 
fact, the occupancy of both Prp19 and Ntc20 in syf1-37 cells was also 
decreased to nearly 50% compared to the wild-type cells (Figure 2.22). Thus, I 
concluded that Syf1 functions in transcription elongation as part of the Prp19 
complex.
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Figure 2.21 : The syf1-37 mutation leads to loss of Syf1 from the transcribed 
genes 
Ch Ps of TAP-Syf1, TAP-syf1-37 and Rpb3-TAP (RNAPII) in SYF1 and syf1-37 cells 
grown at permissive temperature (30°C) were quantified by real-time (RT)-PCR 
using the primer pairs shown in Figure 2.10. The occupancy ratio of Syf1 over 
RNAPII over the NTR was calculated and the values for SYF1 were set to 1. 
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Figure 2.22: The syf1-37 mutation leads to loss of Prp19 and Ntc20 from the 
transcribed genes
Experiment as in Figure 2.21, except the occupancy of Prp19 and Ntc20 were 
assessed.
The syf1-37 mutation causes a lower level of the whole Prp19 complex at the 
transcribed genes most likely due to the lack of its C-terminal region. I 
wondered whether in this mutant th  ability of syf1-37 to interact with other 
proteins would also be affected, e.g. Syf1/syf1-37 with RNAPII or Syf1/syf1-37 
with THO/TREX. Thus, I assessed this by purifying TAP-tagged Syf1/syf1-37 
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and analyzing copurification of RNAPII and THO/TREX by western blotting. 
Both Syf1 and syf1-37 copurified the same amounts of Prp19 complex 
component and Hpr1 indicating that without its C-terminal region syf1-37 could 
still interact with the whole Prp19 complex and THO/TREX. However, 
copurification of Rpb1, the largest subunit of RNAPII, with syf1-37 was largely 
decreased suggesting that the interaction between RNAPII and the Prp19 
complex is impaired by the lack of C-terminal region of Syf1 (Figure 2.23). 
This result therefore indicates that the C-terminus of Syf1 is necessary for the 
interaction between the Prp19 complex and RNAPII and consequently for the 
recruitment of the whole Prp19 complex to the transcription machinery. 
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Figure 2.23 : The C-terminus of Syf1 mediates the interaction between the 
Prp19 complex and RNAPII
The interaction of syf1-37 with RNAPII was strongly decreased while the interaction 
with the Prp19 and the TREX complex was not affected. TAP-Syf1 and TAP-syf1-37 
were purified from cells expressing Hpr1-HA and copurification of RNAPII and Hpr1 
assessed by western blotting using the 8WG16 antibody, recognizing the largest 
subunit of RNAPII Rpb1, or an α-HA antibody, respectively. Copurifying proteins 
were identified by mass spectrometry  and indicated on the right. A non-tagged strain 
served as negative control. IN: input, IP: immunoprecipitation, Coomassie: EGTA 
eluates of the TAP purifications.
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2.7 The Prp19 complex is required for TREX occupancy at 
transcribed genes
The genetic interaction between SYF1 and the THO complex and the function 
of Syf1 in transcription indicate that there might be an interplay between the 
Prp19 and the TREX complex. Therefore, I assessed whether the occupancy 
of Hpr1, a component of the THO complex, is influenced by Syf1 and vice 
versa. While the occupancy of Syf1 relative to RNAPII was not affected by 
deletion of HPR1 (Figure 2.24), Hpr1 occupancy relative to RNAPII was 
reduced in syf1-37 cells approximately to 50% compared to the wild-type cells 
which is coincident with nearly 50% reduction in the Prp19 complex 
recruitment in syf1-37 cells (Figure 2.25). Interestingly, the decrease of THO 
recruitment in syf1-37 cells was not due to a general or nonspecific loss of 
transcription factors at the site of transcription because the recruitment of 
RNAPII (Figure 2.26) and two other transcription elongation factors Paf1 
(Figure 2.27), a component of the PAF complex, and Spt5 (Figure 2.28) was 
not affected by the syf1-37 mutation. Thus, the Prp19 complex is necessary 
for THO occupancy at transcribed genes.
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Figure 2.24: Deletion of HPR1 does not affect occupancy of Syf1
ChIP experiments of Syf1-TAP in wild-type and Δhpr1 cells were quantified by RT-
PCR using the primer pairs shown in Figure 2.10. The ratio of Syf1 occupancy 
relative to RNAPII over the NTR was calculated and the values for wild-type were set 
to 1.
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Figure 2.25: Mutation of SYF1 leads to loss of the THO complex from the 
transcribed gene 
ChI s of Hpr1-TAP in SYF1 and syf1-37 cells grown at permissive temperature, 
30°C, were quantified by  RT-PCR using the primer pairs shown in Figure 2.10. The 
ratio of the occupancy of Hpr1 relative to the occupancy of RNAPII over the NTR 
was calculated and the values for SYF1 were set to 1. 
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Figure 2.26: Mutation of SYF1 does not lead to loss of the RNAPII from the 
transcribed gene 
ChIPs of Rpb3-TAP in SYF1 and syf1-37 cells grown at the permissive temperature, 
30°C, were quantified by  RT-PCR using the primer pairs shown in Figure 2.10. The 
ratio of the occupancy of Rpb3 over the NTR was calculated and the values for 
SYF1 were set to 1. 
Figure 2.27: Mutation of SYF1 does not lead to loss of the Paf1 from the 
transcribed gene 
ChIPs of Paf1-TAP in SYF1 and syf1-37 cells grown at the permissive temperature, 
30°C, were quantified by  RT-PCR using the primer pairs shown in Figure 2.10. The 
ratio of the occupancy of Paf1 relative to the occupancy of RNAPII over the NTR was 
calculated and the values for SYF1 were set to 1. 
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Figure 2.28: Mutation of SYF1 does not lead to loss of the Spt5 from the 
transcribed gene 
ChIPs of Spt5-TAP in SYF1 and syf1-37 cells grown at the permissive temperature, 
30°C, were quantified by  RT-PCR using the primer pairs shown in Figure 2.10. The 
ratio of the occupancy of Spt5 relative to the occupancy of RNAPII over the NTR was 
calculated and the values for SYF1 were set to 1.
It has been shown that the THO subcomplex is required for the efficient 
recruitment of other TREX components such as mRNA export factors Sub2 
and Yra1 to the site of transcription. Since the recruitment of THO is reduced 
in syf1-37 cells, I wondered whether Sub2 and Yra1 recruitment is also 
affected by the mutation. I assessed the recruitment of both proteins in 
syf1-37 cells and found that their occupancies were also decreased (Figure 
2.29). However, the reduction in occupancy of both Sub2 and Yra1 at 
transcribed genes is lower than the decrease of Hpr1. This is most likely due 
to the fact that Sub2 and Yra1 are still partially recruited to genes even in the 
complete absence of Hpr1 (Zenklusen et al. 2002). Taken together, the Prp19 
complex is needed for effective recruitment of the TREX complex to 
transcribed genes.
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Figure 2.29: Syf1 is required for an efficient recruitment of TREX complex to 
the transcribed genes
Experiment as in Figure 2.25, except the occupancy of Sub2 and Yra1 were 
assessed.
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2.8 The C-terminal TPR motifs of Syf1, which are important for 
the interaction of the Prp19 complex with RNAPII, are not 
interchangeable
Deletion of the last three C-terminal TPR motifs of Syf1 significantly impairs an 
interaction between the Prp19 complex and RNAPII and causes a reduction in 
Prp19 occupancy at transcribed genes in vivo. Thus, the C-terminal domain of 
Syf1 is an important binding interface between the Prp19 complex and 
RNAPII.
Since there are 15 TPR motifs in Syf1, I then asked whether these motifs, 
especially at the C-terminal region of Syf1, are interchangeable. Within the C-
terminus of Syf1, the 13th of the 15 TPR motifs seems to be specifically crucial 
for the interaction since additional deletion of only 13th TPR motif (syf1-∆13) 
leads to synthetic lethal with ∆hpr1, while deletion of the two most C-terminal 
TPR motifs (XIV and XV, syf1-∆14) does not cause any genetic interaction 
with ∆hpr1. To answer this question, I constructed fusion mutants of six 
different combinations of two other TPR motifs (I+II, III+IV, VI+VII, VII+VIII, IX
+X, or XI+XII) of Syf1 to the syf1-∆13 deletion mutant (Figure 2.30). 
Surprisingly, all the mutants are still synthetic lethal with ∆hpr1. Therefore, the 
mere addition of TPR motifs to the 3ʼ-end of the truncated Syf1 does not 
rescue functionality of Syf1 in transcription indicating that its C-terminal TPR 
motifs are not interchangeable. 
Similarly, deletion of the N-terminal five TPR motifs of Syf1 (I-V) does not 
cause a synthetic lethality with ∆hpr1 (Figure 2.31). This results indicates that 
these TPR motifs are most likely not crucial for the physical interaction 
between the Prp19 complex and RNAPII as well as the function of the Prp19 
complex in transcription. Interestingly, however, when the 6th TPR motif of 
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Syf1 is deleted, the cells become lethal indicating its essential role for the 
cells.
Figure 2.30: The C-terminal TPR motifs of Syf1 are important for the interaction 
of the Prp19 complex with RNAPII and are not interchangeable
Addition of six different combinations of two other TPR motifs of Syf1 to the syf1-
∆13 deletion mutation cannot rescue synthetic lethality with ∆hpr1. 
Figure 2.31: The deletion of N-terminal TPR motifs of Syf1 does not lead to 
synthetic lethality with ∆hpr1
51
2.9 The C-terminus of Syf1 and the interaction with Yju2
The C-terminus of Syf1 seems to be important for an interaction between the 
Prp19 complex and RNAPII. Interestingly, it has been reported recently that 
the C-terminus of Syf1 (484-754 amino acids) interacts with Yju2, a novel 
essential splicing factor which promotes the first catalytic reaction of splicing 
(Chang et al. 2009). Therefore, the interaction of Yju2 with Prp19 complex 
could be impaired in syf1-37 cells, expressing Syf1 that lacks the four most C-
terminal TPR motifs, and as a result transcription efficiency is decreased. 
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Figure 2.32: Yju2 associates with Prp19 complex in syf1-37 cells
Prp19 complex was purified using either TAP-Syf1 or TAP-syf1-37 and copurification 
of myc-tagged Yju2 assessed by western blotting with α-myc antibody (α-myc). A 
non-tagged strain served as negative control. IP: immunoprecipitation, Coomassie: 
TEV eluate of the TAP purification.
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To answer these questions, first Prp19 complex was purified using a strain 
expressing either TAP-Syf1 or TAP-syf1-37 and copurification of myc-tagged 
Yju2 was assessed by western blotting. As shown in Figure 2.32, Yju2 
copurified with the Prp19 complex regardless of presence or absence of the 
C-terminus of Syf1.
Second, to test whether YJU2 is implicated in transcription, I tested yju2-ts cell 
for a sensitivity to 6-AU, a drug that impairs transcription elongation. As shown 
in Figure 2.33, yju2 ts cell did not confer 6-AU sensitivity. These results 
suggest that YJU2 might not involve in transcription and is most likely not the 
cause of the impaired transcription in the syf1-37 cells.
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Figure 2.33: yju2 ts cell did not confer 6-AU sensitivity
10-fold serial dilutions of yeast cells expressing wild-type YJU2 or yju2 ts allele were 
spotted onto SDC-(ura) plates containing solvent (DMSO) or 50 or 100 μg/ml 6-AU 
and incubated for 2 days at 30°C.
2.10 The syf1-37 mutation does not lead to an mRNA export 
defect
The genetic interaction between SYF1 and the THO complex and the reduced 
recruitment of the TREX components in syf1-37 cells suggest a role of Syf1 in 
mRNA export. Therefore I assessed an mRNA export defect in syf1-37 cells. 
As a positive control for nuclear accumulation of mRNA ∆hpr1 cells were 
used. While deletion of the HPR1 gene led to a block of mRNA export at 37°C, 
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syf1-37 cells showed no defect on mRNA export (Figure 2.34). This result 
suggests that although the recruitment of TREX to transcribed genes in the 
syf1-37 cells is reduced, it is still sufficient for effective mRNA export to the 
cytoplasm.
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syf1-37
!hpr1
Cy3 DAPI Merge
Figure 2.34: The syf1-37 cells do not display an mRNA export defect
Cells were grown at 37°C for three hours and oligo-dT in situ hybridization was 
performed. The poly(A)-tail of bulk mRNA was visualized by using a Cy3-labelled 
oligo(dT) probe and nuclei of the cells were stained with 4',6-diamidino-2-
phenylindole (DAPI). While ∆hpr1 cells display  mRNA export defect, wild-type (wt) 
and syf1-37 cells do not show any mRNA accumulation in the nucleus.
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2.11 Transcription impairment in the syf1-37 cells does not lead 
to a hyperrecombination phenotype
It has been shown previously that the mutation of the THO complex impairs 
transcription in vivo. In these mutants, the transcribed mRNA can form RNA-
DNA hybrid, so-called R-loop, which links an impairment of both transcription 
and transcription-associated recombination. Moreover, this hyper-
recombination is only observed when transcription goes through either the 
DNA repeats or the intervening regions flanked by the repeats, suggesting that 
transcription in crucial for the hyperrecombination phenotype.
Since transcription is impaired in syf1-37 cells, I asked whether this 
transcription impairment would cause transcription-associated recombination. 
To answer this question, a hyperrecombination assay was performed by using 
the L-lacZ and L-PHO5 system, containing either lacZ or PHO5 gene flanked 
by leu2 direct repeats (Figure 2.35, upper panel) under the control of 
constitutive LEU2 promoter. In the absence of the THO complex, R-loops are 
formed due to impaired transcription elongation and as a result the mutant 
shows a hyperrecombination phenotype (Figure 2.35, lower panel, ∆hpr1). 
Importantly, though the syf1-37 mutant displays a transcription defect, its 
recombination rates are comparable to wild-type (Figure 2.35, lower panel, 
syf1-37). This result suggests that although the recruitment of TREX to 
transcribed genes and the transcription efficiency in the syf1-37 cells are 
reduced, the amount of TREX is probably sufficient for maintaining the 
genomic stability.
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Figure 2.35: Recombination frequencies of wild-type, syf1-37 and ∆hpr1 cells 
using direct repeat systems
(A) Schematic diagram of the deletion resulting from recombination between the 
direct repeats used. (B) Recombination frequencies in wild-type, syf1-37 and ∆hpr1 
cells transformed with the plasmid containing either L-PHO5 or L-lacZ construct. 
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3. Discussion
3.1 The Prp19 complex functions in transcription elongation 
and is necessary for TREX occupancy at transcribed genes
In the last decade, the Prp19 complex has been studied extensively in its 
conserved function, i.e. splicing. It forms a heteromeric complex which is also 
known as the nineteen complex (NTC) in budding yeast and the hPrp19/
CDC5L complex in higher cells. The Prp19 complex is one of several non-
snRNPs which play a crucial role in splicing and is necessary for the activation 
of the spliceosome. 
Here I show  that in budding yeast the Prp19 complex has an additional role in 
gene expression, i.e. transcription elongation. The complex is recruited to both 
intron-containing and intronless genes in a transcription-dependent manner. 
Furthermore, mutation of SYF1, an essential and conserved component of the 
Prp19 complex, causes a decreased occupancy of the whole Prp19 complex 
at transcribed genes and reduces transcriptional activity. Moreover, the 
syf1-37 mutation reduces RNAPII processivity indicating a role in transcription 
elongation. 
In addition, I identify SYF1 as the first factor required for occupancy of the 
TREX complex since TREX recruitment to genes is specifically decreased in 
syf1-37 cells. However, for some genes, e.g. PMA1 and DBP2, the Prp19 
complex is not necessary for TREX recruitment at the 5ʼ-end. Therefore, there 
might be other factors responsible for TREX recruitment to genes at these 
sites. Notably, the occupancy of two other transcription elongation factors, i.e. 
Paf1 and Spt5, is not affected by the mutation of SYF1, indicating that the 
reduction of TREX occupancy is specific to SYF1 mutation and most likely to 
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the C-terminal region of Syf1. It is interesting to remark that the PAF complex 
leaves the transcribing RNAPII downstream of the polyadenylation site as 
TREX does (Kim et al. 2004), but apparently depends on other factors than 
SYF1 or TREX for recruitment. It has been shown that THO is important for 
efficient transcription elongation by ensuring the stability of the transcription 
machinery on the chromatin template (Mason and Struhl 2005). Consistent 
with a requirement of the THO complex for RNAPII processivity, the syf1-37 
cells show  impaired processivity of RNAPII in the presence of 6-AU. Thus, the 
decreased THO/TREX occupancy in the syf1 mutant cells seems to be 
sufficient for efficient RNAPII processivity under normal conditions, but causes 
impaired RNAPII processivity when transcription is blocked in the presence of 
6-AU.
Interestingly, even though the occupancy of the components of the TREX 
complex Hpr1, Sub2 and Yra1 is decreased to approximately 50% in the 
syf1-37 cells compared to the wild-type, the defect on nuclear mRNA export 
and the hyperrecombination phenotype are not observed suggesting that the 
amount of TREX is still sufficient for its functions.
3.2 Prp19 E3 ligase activity and transcription
Interestingly, Prp19 contains a U-box domain and has E3 ubiquitin ligase 
activity in vitro (Hatakeyama et al. 2001; Ohi et al. 2003). It has been shown 
recently that this catalytic activity of Prp19 is crucial for structural 
rearrangements during the splicing reaction (Song et al. 2010). Prp19 
ubiquitylates Prp3, a component of U4 snRNP, where non-proteolytic K63-
linked chains are formed. The modification of Prp3 enhances the interaction 
between Prp3 and Prp8, the component of U5 snRNP, and consequently 
stabilizes the U4/U6.U5 tri-snRNP. In the syf1-37 mutant, the interaction 
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between Prp19 complex and the components of U5 snRNP, e.g. Prp8 and 
Brr2, does not seem to be affected as shown in Figure 2.23. Nevertheless, it is 
still questionable that, in addition to its structural function to stabilize the 
recruitment of TREX to genes, the E3 ligase activity of Prp19 might be 
essential for its role in transcription. 
Remarkably, one of the component of the TREX complex Hpr1 is 
polyubuiquitylated and degraded. Interestingly, though, the ubiquitylated form 
of Hpr1 interacts with the ubiquitin-associated (UBA) domain of the mRNA 
export receptor Mex67. This interaction recruits Mex67 to transcribed genes 
and transiently protects Hpr1 from degradation by the proteasome (Gwizdek 
et al. 2006). However, when I purified Hpr1 from SYF1 and syf1-37 cells and 
quantified Hpr1 ubiquitylation, the modification was not affected. This result is 
consistent with the idea that the E3 ligase activity of Prp19 is not affected in 
syf1-37 cells. Therefore, it is still a challenge whether the E3 ligase activity of 
Prp19 is crucial for its function in transcription as well as what its substrate(s) 
might be.
3.3 The TPR motifs of Syf1
The TPR motif displays a large degree of sequence diversity but structural 
comparison shows a highly conserved three dimensional structure consisting 
of two anti-parallel alpha helices separated by a turn. Syf1 contains 15 TPR 
motifs and interestingly the motifs are not interchangeable. This suggests that 
the different TPR motifs of Syf1, especially at the C-terminus, might contain a 
specific residue important for a post-translational modification and/or for 
protein-protein interaction and consequently for its function. Thus, it is still an 
open question in terms of what the difference between each TPR motif is and 
how it regulates the function of Syf1. 
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Interestingly, it has been shown recently that the C-terminus of Syf1 interacts 
with Yju2, a novel splicing factor which promotes the first catalytic reaction of 
splicing (Chang et al. 2009). However, Yju2 binds to syf1-37, which lacks the 
four most C-terminal TPR motifs, and does not confer 6-AU sensitivity. Other 
regions of the C-terminus of Syf1 might play a role in this interaction. These 
results are consistent with the fact that in syf1-37 cells the Prp19 complex is 
still intact and splicing not defective. 
3.4 The function of the Prp19 complex in recruiting TREX to 
genes might be conserved among eukaryotes
In higher eukaryotic cells, where splicing occurs at most sites of mRNA genes, 
TREX is recruited to the mRNA during splicing (Masuda et al. 2005; Wahl et 
al. 2009). In yeast, however, TREX is recruited in a transcription-dependent 
manner. Here I show that the Prp19 complex, so far known as a component of 
the splicing machinery, recruits TREX to genes in yeast. 
During splicing, a highly dynamic molecular machine, the spliceosome, is 
assembled in a stepwise manner onto the mRNA and forms several 
intermediates called complex E, A, B, B* and C ((Wahl et al. 2009) and 
references therein). Briefly, the U1 snRNP binds 5ʼ-splice site and forms the E 
complex. Then the U2 snRNP recognizes the branch point sequence of the 
pre-mRNA and forms the A complex. Subsequently, binding of the pre-
assembled U4/U6.U5 tri-snRNP leads to the B complex. Additional factors as 
well as extensive structural rearrangements destabilizing the association of U1 
and U4 snRNPs with the catalytic core of spliceosome forms the catalytically 
activated B* complex. After the first transesterification reaction, the C complex 
is formed and catalyzes the second step of splicing.
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Interestingly, the hPrp19 and its associated complexes containing XAB2/hSyf1 
are present in the B complex while TREX components, such as THOC1/hHpr1 
and UAP56/hSub2, are found only later when the C complex is formed. As the 
Prp19 complex is part of the spliceosome before the presence of TREX, it 
might recruit or help recruit the TREX complex to the spliceosome during the 
splicing reaction. Therefore, the role of the Prp19 complex in recruiting TREX 
to the mRNA might be conserved in higher eukaryotes. 
In summary, I have identified the Prp19 complex as a novel transcription 
elongation factor which is the first factor essential for TREX occupancy at 
transcribed genes. 
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4. Materials
4.1 Consumables and chemicals
Consumables and chemicals were purchased from the following companies: 
Acros Organics (Geel, Belgium), Applichem (Darmstadt), Applied Biosciences 
(Darmstadt), Apollo Scientific Limited (Bredbury, UK), Axon (Kaiserslautern), 
Becton Dickinson, (Heidelberg), Beckman Coulter (Krefeld), Biaffin (Kassel), 
Biomol (Hamburg), Biorad (Munich), Biozym (Hess. Oldendorf), Chemicon 
(Temecula, Canada), Fermentas (St. Leon- Rot), Formedium (Norwich, UK), 
GE Healthcare (München), Gilson (Bad Camberg), Invitrogen (Karlsruhe), 
Macherey & Nagel (Düren), Medac (Hamburg), Medigenomix (München), 
Membra Pure (Bodenheim), Merck Biosciences (Darmstadt), Millipore 
(Molsheim, France), Mobitec (Göttingen), MP Biomedical (Illkirch, France), 
NEB (Frankfurt), Neolab (Heidelberg), Nunc (Wiesbaden), Peske (Aindling-
Arnhofen), Promega (Mannheim), Qiagen (Hilden), Roche (Mannheim), Roth 
(Karlsruhe), Santa Cruz (Santa Cruz, USA), Sarstedt (Nümbrecht), Semadeni 
(Düsseldorf), Serva (Heidelberg), Sigma (Taufkirchen), Stratagene 
(Amsterdam, The Netherlands) and VWR (Ismaning). 
4.2 Commercially available kits 
The following commercially available kits were purchased from these 
companies: DC Protein Assay (Biorad, München), ECL kit (Applichem, 
Darmstadt), Nucleobond AX PC100, Nucleospin Mini, Nucleospin extract (all 
Macherey & Nagel, Düren), RNeasy MinElute Cleanup Kit (Quiagen, Hilden), 
and Phusion Hot Start II High-Fidelity DNA Polymerase (Finzymes, Finland)
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4.3 Equipments
The following commercially available equipments were purchased from these 
companies: Beckman DU650 spectrophotometer, L80 Ultracentrifuge, SW32 
rotor, SW40 rotor, (Beckman Coulter, Krefeld), T3 Thermocycler (Biometra, 
Goettingen), Gel dryer model 583, Mini-Protean II system (Biorad, München), 
DNA engine (Biozym, Hess Oldendorf), Lumat LB9507 (EG&G Berthold), 
bead mill (Fritsch, Idar-Oberstein), Thermomixer compact, Eppendorf 
centrifuge 5415D, 5415R (Eppendorf, Wesseling-Berzdorf), peristaltic pump 
(GE Healthcare, München), Rotanda, 46R (Hettich, Tuttlingen), Ika Vibrax 
VXR basic (Ika, Staufen), Heraeus Hera Freeze (Kendro, Langenselbold), 
Kodak X omat M35 (Kodak), Kühner ISF-1-V (Kühner AG, Switzerland), 
Elektrophoresis Power Supply Consort E835, Heidolph shaker duomax 1030, 
Rotator, Thermostatcabinet Aqualytic, Vortex Genie (Neolab, Heidelberg), 
Innova 44 shaking incubator (New Brunswick Scientific, Nürtingen), Olympus 
BX60 fluorescence microscope (Olympus, Hamburg), Semi-dry blotting device 
(Peqlab, Erlangen), Tri Carb Liquid Scintillation Analyzer (Perkin Elmer, 
Rodgau), Dissection microscope manual MSM (Singer, Somerset, UK), 
RP80AT-364, Sorvall Evolution, Sorvall RCM120Ex, SLC6000, SS34 rotor 
(Thermo Fisher Scientific), Image reader LAS-3000 (Fujifilm), STORM 860 
and Typhoon 9400 (GE Healthcare)
4.4 Radioactivity
Radioactivity, [γ-32P]-ATP (370 MBq/ml, 10 mCi/ml), was obtained from GE 
Healthcare.
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4.5 Enzymes
Calf Intestine Alkaline Phosphatase (1 U/µl; Fermentas, St. Leon-Rot), 
restriction endonucleases (BamHI, EcoRI, HindIII, NheI, NotI, SphI, PstI, SacI, 
SalI, SpeI, SphI, XbaI, XhoI; Fermentas, St. Leon-Rot), RevertAid H Minus M-
MuLV Reverse Transcriptase (Fermentas, St. Leon-Rot), T4-DNA Ligase 
(Fermentas, St. Leon-Rot), RiboLock Ribonuclease Inhibitor (Fermentas, St. 
Leon-Rot), Micrococcal Nuclease (Roche, Mannheim) and Zymolyase 
20000T/100000T (Medac, Hamburg)
4.6 Antibodies
Source Dilution Company
Primary antibodies
α-Pgk1 mouse 1:1000 Molecular Probes
α-HA mouse 1:1000 Roche Applied Science
α-Npl3 rabbit 1:5000 Siebel and Guthrie, 1996
α-Rpb1 (N-term; yN-18) goat 1:1000 Santa Cruz
α-Rpb1 (CTD; 8WG16) mouse 1:1000 Covance
Peroxidase α-
Peroxidase complex 
(PAP)
rabbit 1:5000 Sigma
Secondary antibodies
α-mouse IgG HRPO goat 1:3000 Biorad
α-rabbit IgG HRPO goat 1:3000 Biorad
α-goat IgG HRPO rabbit 1:5000 Sigma
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4.7 Oligonucleotides
Oligo Sequence Description
Cloning primers
TAP-PstI-f ATTCTGCAGATGGCAGGCCTT
GCGCAAC
for cloning pNOPTAP
TAP-BamHI-r ATTGGATCCAAGTGCCCCGGA
GGATGAGA
for cloning pNOPTAP
pNOP-XhoI-f ATTCTCGAGTCCTGTACTTGCT
GATATTGTGG
for cloning pNOPTAP
pNOP-PstI-r ATTCTGCAGTACTGTTTTAGTT
GATTTGAGTT
for cloning pNOPTAP
SpeI-SYF1-f TAGACTAGTTGTGCATAGAGCC
CTTGTCT
for cloning SYF1 into 
pRS315
SYF1-XhoI-r ATGCTCGAGAACCTTCGGAAA
GGGAAAAA
for cloning SYF1 into 
pRS315
BamHI-SYF1-f TCGGAAAGTTTGGGATCCTG for cloning C-terminal 
truncation of SYF1
NheI-
SYF1-821-r 
ATTGCTAGCTACTCATGGCTAA
CACTAGCTGAATCAATGAGCAT
G
for cloning C-terminal 
truncation of SYF1
NheI-
SYF1-794-r 
AATGCTAGCTTACTTATCCCCAT
GTTTTAACTC
for cloning C-terminal 
truncation of SYF1
NheI-
SYF1-755-r 
AATGCTAGCTATATAGAGCTCT
CGAAATCTG
for cloning C-terminal 
truncation of SYF1
NheI-
SYF1-719-r
AATGCTAGCTAAGTAGACTCGG
CCTTGGAAA
for cloning C-terminal 
truncation of SYF1
NheI-
SYF1-679-r 
AATGCTAGCTACAGACCACTTA
TCCTTTCTT
for cloning C-terminal 
truncation of SYF1
SYF1-SalI-f ATTGTCGACATGTCAGCATACA
TCGCAATG
for subcloning SYF1 and 
syf1-37 into pNOPTAP
SYF1-SpeI-rev ATACTAGTAAAGCGGCTAGAGG
GGACT
for subcloning SYF1 and 
syf1-37 into pNOPTAP
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Oligo Sequence Description
GAL10-prom-
SalI-f
ATCGTCGACTGGTTATGCAGCT
TTTCCATT
for cloning pRS316-
GAL10-ACT1
GAL10-prom-
SpeI-r
ACTACTAGTCTTTCACTTTGTAA
CTGAGCTGTC
for cloning pRS316-
GAL10-ACT1
ACT1-cds-
SpeI-f
TATACTAGTATGGATTCTGGTAT
GTTCTAGCG
for cloning pRS316-
GAL10-ACT1
ACT1-cds-NotI-
r
ATTGCGGCCGCTCTTCTGGGG
CAACTCTCAA
for cloning pRS316-
GAL10-ACT1
TAP-tagging primers
NTC20-f GAATAATAAGGAAAAGGGTATT
ACAGGAACCCGACCGTGACAA
TGATGATAGCGGCTCCATGGA
AAAGAGAAG
for TAP tagging NTC20
NTC20-r CTTTCCCAGCCAACCCAATGA
AGTCTTGCGCACGCAATTGGT
TGTAATTATCCGATACGACTCA
CTATAGGG
for TAP tagging NTC20
PRP19-f CCGCTATTCTGAAGACAAATGA
TAGTTTCAATATTGTTGCATTGA
CACCCTCCATGGAAAAGAGAA
G
for TAP tagging PRP19
PRP19-r GTTACTACTATTACACAGGTTTA
TTTAGAAAGTACAAACGTGTCA
GCGTATTACGACTCACTATAGG
G
for TAP tagging PRP19
PAF1-f GTTCATACTGAACAAAAACCAG
AGGAAGAAAAGGAAACTTTAC
AAGAAGAATCCATGGAAAAGA
GAAG
for TAP tagging PAF1
PAF1-r GTAAAAAGAACTACAGGTTTAA
AATCAATCTCCCTTCACTTCTC
AATATTTACGACTCACTATAGG
G
for TAP tagging PAF1
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Oligo Sequence Description
SPT5-f CAACCAAGGAAATAAGTCAAAC
TATGGTGGTAACAGTACATGGG
GAGGTCATTCCATGGAAAAGA
GAAG
for TAP tagging SPT5
SPT5-r GTCTTTTTTATTGATTTCTTCTT
GGGTGATATTGGTTCTCCTTTT
GGTGATACGACTCACTATAGGG
for TAP tagging SPT5
Primer extension oligos
U1 CAAGGGAATGGAAACGTCAG in vivo transcription 
assay
SCR1 TTTACGACGGAGGAAAGACG in vivo transcription 
assay
GAL10 TTCCAGACCTTTTCGGTCAC in vivo transcription 
assay
ACT1 GTTTTCCCAGTCACGACGTT in vivo transcription 
assay
RT-PCR primers
NTR-f TGCGTACAAAAAGTGTCAAGA
GATT
ChIP experiment
NTR-r ATGCGCAAGAAGGTGCCTAT ChIP experiment
ADH1-5'-f GTTGTCGGCATGGGTGAAA ChIP experiment
ADH1-5'-r GGCGTAGTCACCGATCTTCC ChIP experiment
ADH1-M-f AGCCGCTCACATTCCTCAAG ChIP experiment
ADH1-M-r ACGGTGATACCAGCACACAAG
A
ChIP experiment
ADH1-3'-f TTGGACTTCTTCGCCAGAGG ChIP experiment
ADH1-3'-f GCCGACAACCTTGATTGGAG ChIP experiment
PGK1-5'-r TTGCCAACCATCAAGTACGTTT ChIP experiment
PGK1-5'-r CCCAAGTGAGAAGCCAAGACA ChIP experiment
PGK1-3'-f GAAGACGGCACCAGCCAAT ChIP experiment
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Oligo Sequence Description
PGK1-3'-r TGACAAGATCTCCCATGTCTCT
ACTG
ChIP experiment
PMA1-M-f GTTTTTCGTCGGTCCAATTCA ChIP experiment
PMA1-M-r AACCGGCAGCCAAAATAGC ChIP experiment
PMA1-3'-f CAGAGCTGCTGGTCCATTCTG ChIP experiment
PMA1-3'-r GAAGACGGCACCAGCCAAT ChIP experiment
PDR5-5'-f TCTCCATCTGTGGATCCAAATT
T
ChIP experiment
PDR5-5'-r CGGAATCCAAACCCCTTGT ChIP experiment
PDR5-3'-f GGTGTTGCTAACGTAGACGTC
AA
ChIP experiment
PDR5-3'-r CGGATGGTGGTGTGAATTCTA
G
ChIP experiment
ACT1-5'-f TTTTCACGCTTACTGCTTTTTT
CTT
ChIP experiment
ACT1-5'-r GCTAGAACATACCAGAATCCAT
TGTTAA
ChIP experiment
ACT1-3'-f TCAGAGCCCCAGAAGCTTTG ChIP experiment
ACT1-3'-r TTGGTCAATACCGGCAGATTC ChIP experiment
DBP2-5'-f CCAAAGCCAATCACCACTTTC ChIP experiment
DBP2-5'-r AGCCTTCACTTCATTCAAAACG
T
ChIP experiment
DBP2-3'-f CTTCACCGAACAAAACAAAGG
TT
ChIP experiment
DBP2-3'-r TCGGGAGGAATATTTTGATTAG
CT
ChIP experiment
YLR454-p-f TGGTACCGTCAGGCTAAAATCC ChIP experiment
YLR454-p-r TCGTAGACCCTTGATGAAAAGC
T
ChIP experiment
YLR454-1000-f GATCTCGTGTATGCAATGGAAA
AA
ChIP experiment
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Oligo Sequence Description
YLR454-1000-r ACGGTGACGTTCATTTCTTTCA ChIP experiment
YLR454-2000-f CGGTTTTTATGCCAAGAGATGT
T
ChIP experiment
YLR454-2000-r GCCATCAATTAGGTCCTTTGAA
CT
ChIP experiment
YLR454-4000-f GCCTTCATGTGGCATTGAAA ChIP experiment
YLR454-4000-r TGTATTCTTCGGAACGCCTTTT ChIP experiment
YLR454-8000-f GGAGAATAAAATTGCTGACGAC
ACT
ChIP experiment
YLR454-8000-r GGCTCCGTGTAGGAATTATAAG
TTG
ChIP experiment
GAL1-5'-f GTGACTTCTCGGTTTTACCTTT
AGC
ChIP experiment
GAL1-5'-r AATGGATGGATTTTTCTCGTTC
A
ChIP experiment
GAL1-3'-f GGTGGTTGTACTGTTCACTTG
GTT
ChIP experiment
GAL1-3'-r TCATTGGCAAGGGCTTCTTT ChIP experiment
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4.8 Plasmids
Plasmid Description Reference
pBS1479 plasmid used for C-terminal 
TAP-tagging of a protein by 
genomic integration
(Puig, Caspary et al. 
2001)
pNOPPATA1L plasmid containing the NOP1 
promoter, sequences coding for 
protein A and the TEV cleavage 
site, and the ADH1 terminator
Hellmuth, K. (2002)
pRS314 an ARS-CEN vector with a 
TRP1 marker
(Sikorski and Hieter 
1989)
pRS315 an ARS-CEN vector with a 
LEU2 marker
(Sikorski and Hieter 
1989)
pRS314-MFT1 the coding sequence of MFT1 
plus about 500 bp downstream 
and upstream of the ORF was 
amplified by PCR creating a 
SalI site and a BamHI site and 
cloned into the same sites of 
pRS314
(Hurt, Luo et al. 2004)
pRS314-HPR1 the coding sequence of HPR1 
plus about 500 bp downstream 
and upstream of the ORF was 
amplified by PCR creating a 
SacI site and a HindIII site and 
cloned into the same sites of 
pRS314
(Strasser, Masuda et 
al. 2002)
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Plasmid Description Reference
pNOPTAP the promoter sequence of 
NOP1 was PCR amplified from 
pNOPPATA1L adding XhoI and 
PstI sites and the coding 
sequence of protA-TEV-CBP 
was PCR amplified from 
pBS1761 adding PstI and 
BamHI sites and cloned into 
XhoI and BamHI sites of 
pRS315
this study
pRS315-SYF1 a HincII-SpeI fragment of a 
genomic clone containing SYF1 
was cloned into the SmaI and 
SpeI sites of pRS315
this study
pRS315-syf1-Δ12 the sequence encoding amino 
acids 1-679 of SYF1 was PCR 
amplified from pRS315-SYF1 
adding BamHI and NheI and 
cloned into the same sites of 
pRS315-SYF1
this study
pRS315-syf1-Δ13 the sequence encoding amino 
acids 1-719 of SYF1 was PCR 
amplified from pRS315-SYF1 
adding BamHI and NheI and 
cloned into the same sites of 
pRS315-SYF1
this study
pRS315-syf1-Δ14 the sequence encoding amino 
acids 1-755 of SYF1 was PCR 
amplified from pRS315-SYF1 
adding BamHI and NheI and 
cloned into the same sites of 
pRS315-SYF1
this study
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Plasmid Description Reference
pRS315-syf1-Δ15 the sequence encoding amino 
acids 1-794 of SYF1 was PCR 
amplified from pRS315-SYF1 
adding BamHI and NheI and 
cloned into the same sites of 
pRS315-SYF1
this study
pRS315-syf1-ΔC the sequence encoding amino 
acids 1-821 of SYF1 was PCR 
amplified from pRS315-SYF1 
adding BamHI and NheI and 
cloned into the same sites of 
pRS315-SYF1
this study
pRS315-syf1-1 as pRS315-SYF1 but carrying 
syf1-1
this study
pRS315-syf1-2 as pRS315-SYF1 but carrying 
syf1-2
this study
pRS315-syf1-15 as pRS315-SYF1 but carrying 
syf1-15
this study
pRS315-syf1-34 as pRS315-SYF1 but carrying 
syf1-34
this study
pRS315-syf1-37 as pRS315-SYF1 but carrying 
syf1-37
this study
pNOPTAP-SYF1 the coding sequence of SYF1 
was PCR ampl ified f rom 
pRS315-SYF1 adding SpeI site 
was cloned into the same site 
of pNOPTAP
this study
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Plasmid Description Reference
p N O P T A P -
syf1-37
the coding sequence of syf1-37 
was PCR ampl ified f rom 
pRS315-syf1-37 adding SpeI 
site and cloned into the same 
site of pNOPTAP
this study
pRS316-GAL10-
ACT1
the promoter sequence of 
GAL10 was PCR amplified from 
genomic DNA adding SalI and 
SpeI sites and the sequence of 
the ACT1 ORF PCR amplified 
from genomic DNA adding SpeI 
and NotI and cloned into the 
SalI and NotI sites of pRS316
this study
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4.9 Strains
E. coli strains
DH5α F-, φ80dlacZ∆M15, ∆(lacZYA-argF)U169, deoR, recA1, endA1, 
  hsdR17(rk -, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1
S. cerevisiae strains
Strain Genotype Reference
W303 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; rad5-535
(Thomas and 
Rothstein 1989)
BY4741 MAT a; his3Δ1 leu2Δ met15Δ ura3Δ EUROSCARF
Δhpr1 SYF1 
shuffle
MAT a; ade2-1; his3-11,15; ura3-52; 
leu2-3,112; trp1-1; hpr1::HIS3; 
syf1::kanMX4; pRS316-SYF1
this study
Δmft1 SYF1 
shuffle
MAT a; ade2-1; his3-11,15; ura3-52; 
leu2-3,112; trp1-1; mft1::kanMX4; 
syf1::kanMX4; pRS316-SYF1
this study
GAL1::YLR454 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; TRP1-KL::GAL1-YLR454
(Mason and 
Struhl 2005)
GAL1::YLR454 
RPB3-TAP 
MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; RPB3-TAP::TRP1-KL; 
TRP1-KL::GAL1-YLR454
this study
GAL1::YLR454 
RPB3-TAP Δhpr1
MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; RPB3-TAP::TRP1-KL; 
TRP1-KL::GAL1-YLR454; hpr1::HIS3
this study
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Strain Genotype Reference
GAL1::YLR454 
RPB3-TAP SYF1
MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; RPB3-TAP::TRP1-KL; 
TRP1-KL::GAL1-YLR454; 
syf1::kanMX4; pRS315-SYF1
this study
GAL1::YLR454 
RPB3-TAP 
syf1-37
MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; RPB3-TAP::TRP1-KL; 
TRP1-KL::GAL1-YLR454; 
syf1::kanMX4; pRS315-syf1-37
this study
HPR1-HA TAP-
syf1-37
MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; syf1::kanMX4; 
HPR1-3HA::HIS3; pNOPTAP-syf1-37
this study
HPR1-TAP SYF1 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; HPR1-AP::TRP1-KL; 
syf1::kanMX4; pRS315-SYF1
this study
HPR1-TAP 
syf1-37
MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; HPR1-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-syf1-37
this study
HPR1-TAP Syf1-
HA
MAT alpha; ade2-1; his3-11, 15; 
ura3-52; leu2-3, 112; trp1-1; HPR1-
TAP::TRP1-KL; SYF1-HA::kanMX4
this study
NTC20-TAP SYF1 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; NTC20-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-SYF1
this study
NTC20-TAP 
syf1-37
MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; NTC20-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-syf1-37
this study
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Strain Genotype Reference
PAF1-TAP SYF1 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; PAF1-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-SYF1
this study
PAF1-TAP syf1-37 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; PAF1-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-syf1-37
this study
PRP19-TAP SYF1 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; PRP19-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-SYF1
this study
PRP19-TAP 
syf1-37
MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; PRP19-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-syf1-37
this study
RPB3-TAP SYF1 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; RPB3-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-SYF1
this study
RPB3-TAP 
syf1-37
MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; RPB3-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-syf1-37
this study
SPT5-TAP SYF1 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; SPT5-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-SYF1
this study
SPT5-TAP 
syf1-37
MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; SPT5-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-syf1-37
this study
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Strain Genotype Reference
SUB2-TAP SYF1 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; SUB2-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-SYF1
this study
SUB2-TAP 
syf1-37
MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; SUB2-TAP::TRP1-KL; 
syf1::kanMX4; pRS315-syf1-37
this study
SYF1 MAT a; his3Δ1; leu2Δ0; ura3Δ0; 
syf1::kanMX4; pRS315-SYF1
this study
syf1-37 MAT a; his3Δ1; leu2Δ0; ura3Δ0; 
syf1::kanMX4; pRS315-syf1-37
this study
SYF1 
GAL10::ACT1
MAT a; his3Δ1; leu2Δ0; ura3Δ0; 
syf1::kanMX4; pRS315-SYF1; 
pRS316-GAL10-ACT1
this study
SYF1 shuffle MAT a; his3Δ1; leu2Δ0; ura3Δ0; 
syf1::kanMX4; pRS316-SYF1
this study
syf1-37 
GAL10::ACT1
MAT a; his3Δ1; leu2Δ0; ura3Δ0; 
syf1::kanMX4; pRS315-syf1-37; 
pRS316-GAL10-ACT1
this study
SYF1-HA MAT alpha; ade2-1; his3-11, 15; 
ura3-52; leu2-3, 112; trp1-1; SYF1-
HA::kanMX4
this study
TAP-SYF1 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; syf1::kanMX4; pNOPTAP-
SYF1
this study
TAP-SYF1 Δhpr1 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; HPR1::HIS3; syf1::kanMX4; 
pNOPTAP-SYF1
this study
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Strain Genotype Reference
TAP-syf1-37 MAT a; ade2-1; his3-11, 15; ura3-1; 
leu2-3, 112; trp1-1; can1-100; 
rad5-535; syf1::kanMX4; pNOPTAP-
syf1-37
this study
yju2 ts MAT a ura3Δ0 leu2Δ0 his3Δ1 
can1Δ::LEU2-MFA1pr::His3 yju2-
ts::URA3
Ben-Aroya et al. 
2008
78
5. Methods
5.1 Standard methods
Cloning procedures such as DNA digest with restriction enzymes, CIAP 
dephosphorylation, DNA ligations, and transformation of newly generated 
vectors in Escherichia coli and separation of DNA in agarose gels were done 
according to Sambrook and Russell, CSHL Press, 2001. Commercial 
available kits were used according to manufacturerʼs instructions. 
Amplification of yeast genes or TAP-tags was usually done in a 20 µl Phusion 
PCR reaction using 0.5 µM forward-primer, 0.5 µM reverse-primer, 1 µg yeast 
genomic DNA or 50 pg plasmid DNA mixed with 10 µl 2xPhusion Hot Start II 
High-Fidelity DNA Polymerase (Finzyme). The following amplification protocol 
was used: 30 s 98°C, [10 s 98°C, 30 s at the respective melting temperature, 
30 s/1000 bp 72°C], 35 cycles, 5 min 72°C.
To check for the correct integration of the disruption cassette, colony PCR was 
performed. A 25 µl reaction was assembled, containing 1 µM forward-primer, 1 
µM reverse-primer, 62.5 µM of each dNTP, 750 µM MgCl2 and 1x Taq buffer 
(Fermentas, St. Leon-Rot). Freshly growing cells were picked with a toothpick 
and added to the reaction. The PCR reaction was boiled for 15 min (optional), 
before 1.5 U Taq polymerase (Fermentas, St. Leon-Rot) was added. 
Amplification was performed using the following protocol: [30 s 95°C, 30 s 
45°C, 60 s 72°C] 25 cycles, 2 min 72°C.
79
5.2 Yeast specific techniques
5.2.1 Culture of S. cerevisiae
Yeast cells were grown in either full or synthetic complete medium. Full 
medium contained 1% of yeast extract, 2% of Bacto-peptone, and 2% of 
glucose. Synthetic complete medium contained 0.67% of yeast nitrogen base, 
0.06% of complete synthetic mix (containing all essential amino acids except 
three amino acids and two nucleobases used as auxotrophy markers, i.e. 
leucine, tryptophan, histidine, uracil and adenine) and 2% of glucose. 5-FOA 
was added to a final concentration of 0.1%. 6-AU was used at the 
concentration of 50 µg/ml.
5.2.2 Transformation of yeast cells
Yeasts were grown in a 50-ml culture to an optical density of 0.5 to 1.0, 
harvested and washed once with distilled water. Cells were then washed with 
solution I (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 100 mM CH3COOLi) and 
resuspended in 250 µl of the same buffer. Fifty-microliter of cell suspension 
was mixed with 1-5 µg of plasmid DNA, 10 µg of single strand carrier DNA and 
300 µl of solution II (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 100 mM 
CH3COOLi, 40% PEG-4000) and incubated at room temperature (RT) for 30 
min on a rotator. The suspension was then incubated at 42°C for 10 min, 
following by 3-min incubation on ice. Cells were washed once with water and 
plated on selective medium.
5.2.3 Genomic integration of a tandem-affinity-purification (TAP) tag
The genomic integration of a TAP-tag is achieved by homologous 
recombination of the C-terminal region of the respective gene with a 
transformed PCR-product containing the TAP-tag and an auxotrophy marker 
as described by Seraphin B. For C-terminal tagging, pRS1479 (TRP1) was 
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used as a plasmid template of a PCR. The 5'-primer consisted of ~50 
nucleotides of yeast genomic sequence flanking the integration site prior to 
the stop codon of the gene of interest and 5ʼ-TCCATGGAAAAGAGAAG-3ʼ, 
which anneals to the upstream sequence of calmodulin binding protein (CBP) 
on the plasmid template. The 3'-primer consisted of ~50 nucleotides of yeast 
genomic sequence flanking the integration site directly downstream of the stop 
codon of the gene of interest and 5ʼ-TACGACTCACTATAGGG-3ʼ, which 
anneals downstream of the selection marker on the plasmid template. The 
PCR product was then purified by NucleoSpin Extract II (Macherey-Nagel, 
Dueren, Germany). The purified DNA was then transformed into the yeast 
cells to achieve integration into the genome by homologous recombination. 
Transformants were then tested for the presence of the TAP-tag by western 
blotting.
5.2.4 Crossings of yeast strains to test for synthetic lethality
Synthetic lethality can be assessed by either combining the deletion of two 
nonessential genes or by analyzing combinations between different allelic 
mutations in case of essential genes. Thus, double shuffle strain has to be 
generated. Haploid parental strains carrying opposite mating types were 
mated, diploids picked and sporulated on a YPA plate, on which the diploid 
cells underwent meiosis, divided into four haploid spores, enclosed in a tetrad. 
The tetrads were treated with Zymolyase 100T to lyse yeast cell wall. Spores 
were then dissected and subsequently auxotrophy marker analyzed. 
5.2.5 Dot spots 
One loopful (1 µl) of freshly-growing cells was resuspended in 1 ml of distilled 
water. After five ten-fold serial dilutions were made, 6-8 µl of cell suspensions 
were spotted onto a media plate.
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5.2.6 Isolation of temperature sensitive alleles
Random mutagenesis of the entire SYF1 gene was carried out by using error-
prone PCR in limiting dATP conditions, where 0.2 mM of dATP and 1 mM of 
the other three dNTPs were used. The mutant PCR product was transformed 
along with the XhoI/NheI-digested pRS315-SYF1 into SYF1 shuffle strain for 
cloning by gap repair. Transformants on the SDC-Leu master plate were 
replica plated onto two 5-FOA plates. One 5-FOA plate was incubated at 37°C 
and the other at 30°C. Putative ts mutant colonies were then picked from the 
master plate and restreaked onto a new  5-FOA plate, and the ts phenotype 
was confirmed by repeating the above procedure. Subsequently, colony 
plasmid rescue was performed. Plasmids were sequenced to identify the 
mutations. 
5.3 Tandem affinity purification (TAP)
5.3.1 Cell harvest and lysis
For purification of protein complex from yeast S. cerevisiae, a 2-litre overnight 
culture of an optical density of 3-4 was harvested by centrifugation. Cells were 
washed with water, equilibrated with 25 ml TAP buffer (100 mM NaCl, 50 mM 
Tris-HCl pH 7.5, 1.5 mM MgCl2, 0.15% NP-40) containing protease inhibitor 
mix (1.3 µg/ml pepstat in A, 0.28 µg/ml leupeptin, 170 µg/ml 
phenylmethylsulfonyl fluoride (PMSF), 330 µg/ml benzamidine), and flash-
frozen in liquid nitrogen. After thawed in 37ºC water bath, 10 ml of cells were 
mixed with an equal volume of TAP buffer containing 1 mM dithiothreitol (DTT) 
and protease inhibitor mix and 20 ml of glass beads in a bead mill (Fritsch, 
Idar-Oberstein). Cells were lysed according to the following protocol: 3 x (4 
min, 500 rpm, 2 min break). After the lysis, whole cell lysate was collected, 
82
glass beads washed with 15 ml of TAP buffer, wash fraction collected and 
mixed with original whole cell lysate. Then, the lysate was cleared from 
precipitates by centrifuging at 4 krpm for 10 min at 4°C. The supernatant was 
subjected to an ultracentrifugation at 27 krpm for one hour at 4°C using an 
SW32 rotor. Top fatty phase was removed and clear lysate was collected, 
mixed with glycerin to obtain a final concentration of 5%, flash-frozen in liquid 
nitrogen.
5.3.2 Purification and trichloro-acetic acid (TCA) precipitation
Four-hundred-microliter bed-volume of pre-washed IgG sepharose was 
incubated with the whole cell lysate at 4˚C overnight, collected into a Mobicol 
column and washed with 10 ml of TAP buffer containing 0.5 mM DTT. Next 5 
µl of purified recombinant TEV protease was added together with 120 µl TAP 
buffer into the column. After 1-hour incubation at 16°C, the eluate was 
collected by centrifugation, added to 250 µl bed-volume of calmodulin 
sepharose beads, which is pre-washed with calmodulin binding buffer (TAP 
buffer containing 1 mM DTT and 2 mM CaCl2), incubated on the rotator for 1 
hour at 4°C and washed with 5 ml of calmodulin binding buffer. Bound proteins 
were eluted by incubation with 600 µl of elution buffer (10 mM Tris-HCl pH 8.0, 
5 mM EGTA) at 37°C for 15 min. The eluate was collected, precipitated by 
10% TCA and washed once with acetone. Protein pellet was dried and 
resuspended in 35 µl SDS-sample buffer (62.5 mM Tris-HCl pH 6.8, 2.3% 
SDS, 10% glycerol, 0.05% bromophenolblue and 25 mM DTT). The proteins 
were then separated by SDS-PAGE.
5.4 in vivo transcription assay
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Total cellular RNA was isolated by acidic phenol extraction from cells grown in 
raffinose or shifted to 2% galactose for the indicated time points. The primer 
extension analysis was performed according to a standard method. Briefly, 1 
pmol of 32P-labeled primer (4x106 cpm/pmol) specific for ACT1 mRNA, GAL10 
mRNA, or SCR1 RNA, an RNAPIII transcript that served as a loading control, 
was mixed with 5 μg of RNA, hybridized at 37°C for 5 min, extended by 
reverse transcriptase at 42°C for 1 h, and analyzed on a 6% urea/acrylamide 
sequencing gel. Quantification was performed with a STORM 860 and the 
ImageQuant Software (GE Healthcare). 
5.5 in vitro transcription assay
Yeast nuclear extracts were prepared from 3-liter culture. Transcription 
reactions were carried out in a 25 µl volume. The reaction mixture contained 
200 µg nuclear extract, 150 ng of plasmid template containing either a HIS4 or 
a SER3 promoter (Koschubs et al., 2009), 1x transcription buffer (10 mM 
HEPES pH 7.6, 50 mM potassium acetate, 0.5 mM EDTA, 2.5 mM 
magnesium acetate), 2.5 mM DTT, 192 µg of phosphocreatine, 0.2 µg of 
creatine phosphokinase, 10 U of Ribolock RNase inhibitor (Fermentas), 100 
µM NTPs and 200 ng of recombinant Gcn4. The reaction was incubated at 
18°C or 30°C for 20 min and RNA was isolated by using RNeasy MinElute 
Cleanup kit (Qiagen). Transcripts were analyzed by primer extension using 
0.125 pmol of a fluorescently labeled 5ʼ-Cy5-oligo. Quantification was 
performed with a Typhoon 9400 and the ImageQuant Software (GE 
Healthcare). For the add-back experiment, the Prp19 complex was purified 
until the TEV eluate using a SYF1-TAP strain by TAP method as described 
above except that the TAP buffer containing 500 mM NaCl and the HIS-tagged 
TEV protease was depleted using Ni-NTA agarose. 
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5.6 Splicing assay
Analysis of splicing efficiency was performed by reverse transcription (RT)-
PCR. Products were separated on 2% agarose gels, images recorded digitally 
and ratios between spliced and unspliced products quantified using the 
ImageJ software (NIH, Bethesda, MD, USA).
5.7 SDS-PAGE and western blotting
SDS-PAGE was performed according to Laemmli using the Mini-Protean II cell 
(Biorad, Munich). Separated proteins were transferred onto nitrocellulose 
membrane using a semi-dry blotting apparatus (Peqlab, Erlangen). After 
transfer, the membrane was incubated with blocking buffer (5% nonfat dry milk 
in PBS) for 30 min and incubated with blocking buffer containing the primary 
antibody. After that, the membrane was washed three times with blocking 
buffer and incubated at RT for two hours with blocking buffer containing the 
secondary antibody conjugated with HRP. Then the membrane was washed 
three times with PBS and visualized with an ECL-kit according to 
manufacture's protocol (Applichem).
5.8 Chromatin immunoprecipitation
Cross-linked cells were lysed with an equal volume of glass beads by 
vortexing for 6x 3 min with 3-min breaks on ice. Chromatin lysate was used for 
immunoprecipitation with 15 µl of IgG- or α-Yra1-coupled (Yra1 ChIP) 
Dynabeads for 3 hours at 20°C. After washing and elution, the IP eluates as 
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well as input samples were treated with proteinase K overnight at 65°C. DNA 
was purified by phenol/chloroform extraction. Quantitative PCR with input and 
IP samples was done on an Applied Biosystems StepOnePlus cycler, using 
Applied Biosystemsʼ Power SYBRGreen PCR Master Mix. As negative control, 
primers for the non-transcribed region (NTR) amplifying 174131-174200 on 
chromosome V (Rother et al. 2010) was used. PCR efficiencies (E) were 
determined with standard curves. The occupancy of each factor at the 
respective gene was calculated as its enrichment at the respective gene 
relative to NTR according to [E^(CTIP-CTInput)]NTR / [E^(CTIP-CTInput)]gene. For 
evaluation of processivity, data is expressed as the ratio (distribution) of 
RNAPII occupancy in a given strain (or 6-AU condition) relative to the 
promoter position, followed by normalization of each value to the 
corresponding position in the wild-type or untreated strain, which was defined 
as 1. 
For statistical analyses, data are means ± SEM from n=3. Asterisks indicate 
statistical significance (Student's t-test; *p<0.05).
5.9 oligo(dT)-in situ hybridization
10 ml of cells were grown to mid-log phase. 1.25 ml 37% HCOH were added 
and the cell suspension was incubated for 90 min on a turning wheel. For 
mex67-5 cells, a 10 ml culture was shifted for 15 min to 37°C prior to addition 
of formaldehyde. Cells were collected (5 min, 3 krpm) and washed twice with 
5 ml 0.1 M K-phosphate, pH 6.4. After washing with 1 ml of spheroblasting 
buffer (0.1 M K-phosphate, 1.2 M sorbitol), the cells were resuspended in 200 
µl spheroblasting buffer with 100 µg of Zymolyase 100T and incubated for 30 
min at 30°C. Zymolyase treatment was stopped by centrifugation for 4 min at 
2000 rpm and the spheroblasts were attached to pre-coated polylysine slide 
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glass. After 5 min, non-adherent cells were removed by aspiration. Fixation of 
the adherent cells was achieved by putting the slide for 6 min into -80°C-cold 
methanol and for 30 s into -80°C-cold acetone. After air-drying, the cells were 
first rehydrated for 10 min in 100 µl 2x SSC (0.3 M NaCl, 30 mM Na-citrate, 
pH 7.0), before 12 µl prehybridisation buffer (50% formamide, 10% dextran 
sulphate, 125 µg/ml of E.coli tRNA, 500 µg/ml herring sperm DNA, 4x SSC, 
0.02% polyvinyl pyrrolidone, 0.02% BSA, 0.02% Ficoll-400) were applied to 
the cells. After an incubation for 1 h at 37°C, 0.75 µl of 1 pmol/µl oligo-d(T)50 
probe was added, and the slide was incubated overnight in a humid chamber 
at 37°C. Slides were then washed with 100 ml 0.5x SSC for 30 min at RT in a 
staining jar, 5 µg 4',6-diamidino-2-phenylindole (DAPI) were added, followed 
by an incubation for 3 min and further washed with 0.5x SSC for 5 min at RT. 
The slide was dried at RT in the dark, a solution of 80% glycerol in PBS (137 
mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4) was added and the 
slide was covered with a cover slip. Finally, slides were analyzed using an 
Olympus BX60 fluorescence microscope. 
5.10 Frequency of recombination
For assessing the recombination frequencies, six to twelve independent 
colonies per transformants were obtained from SC-trp and recombinants were 
counted as Leu+ colonies on SC-trp-leu plates. Recombination frequencies 
were calculated as the median frequency of those cultures.
87
References
Abruzzi, K.C., Lacadie, S., and Rosbash, M. 2004. Biochemical analysis of 
TREX complex recruitment to intronless and intron-containing yeast genes. 
EMBO J 23: 2620-2631.
Ahn, S.H., Kim, M., and Buratowski, S. 2004. Phosphorylation of serine 2 
within the RNA polymerase II C-terminal domain couples transcription and 3' 
end processing. Mol Cell 13: 67-76.
Ajuh, P., Kuster, B., Panov, K., Zomerdijk, J.C., Mann, M., and Lamond, A.I. 
2000. Functional analysis of the human CDC5L complex and identification of 
its components by mass spectrometry. EMBO J 19: 6569-6581.
Ben-Yehuda, S., Dix, I., Russell, C.S., McGarvey, M., Beggs, J.D., and 
Kupiec, M. 2000. Genetic and physical interactions between factors involved 
in both cell cycle progression and pre-mRNA splicing in Saccharomyces 
cerevisiae. Genetics 156: 1503-1517.
Blatch, G.L. and Lassle, M. 1999. The tetratricopeptide repeat: a structural 
motif mediating protein-protein interactions. Bioessays 21: 932-939.
Carmody, S.R. and Wente, S.R. 2009. nuclear mRNA export at a glance. J 
Cell Sci 122: 1933-1937.
Chan, S.P., Kao, D.I., Tsai, W.Y., and Cheng, S.C. 2003. The Prp19p-
associated complex in spliceosome activation. Science 302: 279-282.
Chang, K.J.,Chen, H.C., and Cheng S.C. 2009. Ntc90 is required for recruiting 
first step factor Yju2 but not for spliceosome activation RNA 15: 1729-1739
Chavez, S., Aguilera, A. 1997. The yeast HPR1 gene has a functional role in 
transcriptional elongation that uncovers a novel source of genome instability. 
Genes & Dev 11: 3459-3470
Das, A.K., Cohen, P.W., and Barford, D. 1998. The structure of the 
tetratricopeptide repeats of protein phosphatase 5: implications for TPR-
mediated protein-protein interactions. EMBO J 17: 1192-1199.
88
David, C.J., Boyne, A.R., Millhouse, S.R., Manley, J.L. 2011. The RNA 
polymerase II C-terminal domain promotes splicing activation through 
recruitment of a U2AF65–Prp19 complex. Genes & Dev 25: 972-983
Gaillard, H., Wellinger, R.E., and Aguilera, A. 2007. A new connection of 
mRNP biogenesis and export with transcription-coupled repair. Nucleic Acids 
Res 35: 3893-3906.
Gwizdek, C., Iglesias, N., Rodriguez, M.S., Ossareh-Nazari, B., Hobeika, M., 
Divita, G., Stutz, F., and Dargemont, C. 2006. Ubiquitin-associated domain of 
Mex67 synchronizes recruitment of the mRNA export machinery with 
transcription. Proc Natl Acad Sci U S A 103: 16376-16381.
Hatakeyama, S., Yada, M., Matsumoto, M., Ishida, N., and Nakayama, K.I. 
2001. U box proteins as a new family of ubiquitin-protein ligases. J Biol Chem 
276: 33111-33120.
Hirose, Y. and Manley, J.L. 2000. RNA polymerase II and the integration of 
nuclear events. Genes & Dev 14: 1415-1429.
Huertas, P. and Aguilera, A. 2003. Cotranscriptionally formed DNA:RNA 
hybrids mediate transcription elongation impairment and transcription-
associated recombination. Mol Cell 12: 711-721.
Hurt, E., Luo, M.J., Rother, S., Reed, R., and Strasser, K. 2004. 
Cotranscriptional recruitment of the serine-arginine-rich (SR)-like proteins 
Gbp2 and Hrb1 to nascent mRNA via the TREX complex. Proc Natl Acad Sci 
U S A 101: 1858-1862.
Iglesias, N. and Stutz, F. 2008. Regulation of mRNP dynamics along the 
export pathway. FEBS Lett 582: 1987-1996.
Jimeno, S., Rondon, A.G., Luna, R., and Aguilera, A. 2002. The yeast THO 
complex and mRNA export factors link RNA metabolism with transcription and 
genome instability. EMBO J, 21: 3526-3535.
Johnson, S.A., Cubberley, G., and Bentley, D.L. 2009. Cotranscriptional 
recruitment of the mRNA export factor Yra1 by direct interaction with the 3' 
end processing factor Pcf11. Mol Cell 33: 215-226.
89
Katahira, J. and Yoneda, Y. 2009. Roles of the TREX complex in nuclear 
export of mRNA. RNA Biol 6: 149-152.
Kim, M., Ahn, S.H., Krogan, N.J., Greenblatt, J.F., and Buratowski, S. 2004. 
Transitions in RNA polymerase II elongation complexes at the 3' ends of 
genes. EMBO J 23: 354-364.
Kohler, A. and Hurt, E. 2007. Exporting RNA from the nucleus to the 
cytoplasm. Nat Rev Mol Cell Biol 8: 761-773.
Komili, S. and Silver, P.A. 2008. Coupling and coordination in gene expression 
processes: a systems biology view. Nat Rev Genet 9: 38-48.
Koschubs, T., Seizl, M., Lariviere, L., Kurth, F., Baumli, S., Martin, D.E., and 
Cramer, P. 2009. Identification, structure, and functional requirement of the 
Mediator submodule Med7N/31. EMBO J 28: 69-80.
Kuraoka, I., Ito, S., Wada, T., Hayashida, M., Lee, L., Saijo, M., Nakatsu, Y., 
Matsumoto, M., Matsunaga, T., Handa, H. et al. 2008. Isolation of XAB2 
complex involved in pre-mRNA splicing, transcription, and transcription-
coupled repair. J Biol Chem 283: 940-950.
Lamb, J.R., Tugendreich, S., and Hieter, P. 1995. Tetratrico peptide repeat 
interactions: to TPR or not to TPR? Trends Biochem Sci 20: 257-259.
Lei, E.P. and Silver, P.A. 2002. Intron status and 3'-end formation control 
cotranscriptional export of mRNA. Genes & Dev 16: 2761-2766.
Li X.L., Manley J.L. 2006. Cotranscriptional processes and their influence on 
genome stability. Genes & Dev 20: 1838-1847
Libri, D., Graziani, N., Saguez, C., and Boulay, J. 2001. Multiple roles for the 
yeast SUB2/yUAP56 gene in splicing. Genes & Dev 15: 36-41.
Luo, M.L., Zhou, Z., Magni, K., Christoforides, C., Rappsilber, J., Mann, M., 
and Reed, R. 2001. Pre-mRNA splicing and mRNA export linked by direct 
interactions between UAP56 and Aly. Nature 413: 644-647.
90
Makarova, O.V., Makarov, E.M., Urlaub, H., Will, C.L., Gentzel, M., Wilm, M., 
and Luhrmann, R. 2004. A subset of human 35S U5 proteins, including Prp19, 
function prior to catalytic step 1 of splicing. EMBO J 23: 2381-2391.
Maniatis, T. and Reed, R. 2002. An extensive network of coupling among 
gene expression machines. Nature 416: 499-506.
Mason, P.B. and Struhl, K. 2005. Distinction and relationship between 
elongation rate and processivity of RNA polymerase II in vivo. Mol Cell 17: 
831-840.
Masuda, S., Das, R., Cheng, H., Hurt, E., Dorman, N., and Reed, R. 2005. 
Recruitment of the human TREX complex to mRNA during splicing. Genes & 
Dev 19: 1512-1517.
Nakatsu, Y., Asahina, H., Citterio, E., Rademakers, S., Vermeulen, W., 
Kamiuchi, S., Yeo, J.P., Khaw, M.C., Saijo, M., Kodo, N. et al. 2000. XAB2, a 
novel tetratricopeptide repeat protein involved in transcription-coupled DNA 
repair and transcription. J Biol Chem 275: 34931-34937.
Nottrott, S., Urlaub, H., and Luhrmann, R. 2002. Hierarchical, clustered 
protein interactions with U4/U6 snRNA: a biochemical role for U4/U6 proteins. 
EMBO J 21: 5527-5538.
Ohi, M.D. and Gould, K.L. 2002. Characterization of interactions among the 
Cef1p-Prp19p-associated splicing complex. RNA 8: 798-815.
Ohi, M.D., Vander Kooi, C.W., Rosenberg, J.A., Chazin, W.J., and Gould, K.L. 
2003. Structural insights into the U-box, a domain associated with multi-
ubiquitination. Nat Struct Biol 10: 250-255.
Orphanides, G. and Reinberg, D. 2000. RNA polymerase II elongation through 
chromatin. Nature 407: 471-475.
Orphanides, G. and Reinberg, D. 2002. A unified theory of gene expression. 
Cell 108: 439-451.
Perales, R. and Bentley, D. 2009. "Cotranscriptionality": the transcription 
elongation complex as a nexus for nuclear transactions. Mol Cell 36: 178-191.
91
Pokholok, D.K., Hannett, N.M., and Young, R.A. 2002. Exchange of RNA 
polymerase II initiation and elongation factors during gene expression in vivo. 
Mol Cell 9: 799-809.
Puig O, Caspary F, Rigaut G, Rutz B, Bouveret E, Bragado-Nilsson E, Wilm 
M, Seraphin B. 2001. The tandem affinity purification TAP method: a general 
procedure of protein complex purification. Methods 24: 218-229.
Reed, R. 2003. Coupling transcription, splicing and mRNA export. Curr Opin 
Cell Biol 15: 326-331.
Reed, R. and Cheng, H. 2005. TREX, SR proteins and export of mRNA. Curr 
Opin Cell Biol 17: 269-273.
Rondon, A.G., Jimeno, S., and Aguilera, A. 2010. The interface between 
transcription and mRNP export: From THO to THSC/TREX-2. Biochim 
Biophys Acta 1799: 533-538.
Rondon, A.G., Jimeno, S., Garcia-Rubio, M., and Aguilera, A. 2003. Molecular 
evidence that the eukaryotic THO/TREX complex is required for efficient 
transcription elongation. J Biol Chem 278: 39037-39043.
Rother, S., Burkert, C., Brunger, K.M., Mayer, A., Kieser, A., and Strasser, K. 
2010. Nucleocytoplasmic shuttling of the La motif-containing protein Sro9 
might link its nuclear and cytoplasmic functions. RNA 16: 1393-1401.
Rougemaille, M., Dieppois, G., Kisseleva-Romanova, E., Gudipati, R.K., 
Lemoine, S., Blugeon, C., Boulay, J., Jensen, T.H., Stutz, F., Devaux, F. et al. 
2008. THO/Sub2p functions to coordinate 3'-end processing with gene-
nuclear pore association. Cell 135: 308-321.
Sikorski RS, Hieter P. 1989. A system of shuttle vectors and yeast host strains 
designed for efficient manipulation of DNA in Saccharomyces cerevisiae. 
Genetics 122: 19-27.
Song, E.J., Werner, S.L., Neubauer, J., Stegmeier, F., Aspden, J., Rio, D., 
Harper, J.W., Elledge, S.J., Kirschner, M.W., and Rape, M. 2010. The Prp19 
complex and the Usp4Sart3 deubiquitinating enzyme control reversible 
ubiquitination at the spliceosome. Genes & Dev 24: 1434-1447.
92
Strasser, K. and Hurt, E. 2000. Yra1p, a conserved nuclear RNA-binding 
protein, interacts directly with Mex67p and is required for mRNA export. 
EMBO J 19: 410-420.
Strasser, K. and Hurt, E. 2001. Splicing factor Sub2p is required for nuclear 
mRNA export through its interaction with Yra1p. Nature 413: 648-652.
Strasser, K., Masuda, S., Mason, P., Pfannstiel, J., Oppizzi, M., Rodriguez-
Navarro, S., Rondon, A.G., Aguilera, A., Struhl, K., Reed, R. et al. 2002. TREX 
is a conserved complex coupling transcription with messenger RNA export. 
Nature 417: 304-308.
Stutz, F. and Izaurralde, E. 2003. The interplay of nuclear mRNP assembly, 
mRNA surveillance and export. Trends Cell Biol 13: 319-327.
Tarn, W.Y., Hsu, C.H., Huang, K.T., Chen, H.R., Kao, H.Y., Lee, K.R., and 
Cheng, S.C. 1994. Functional association of essential splicing factor(s) with 
PRP19 in a protein complex. EMBO J 13: 2421-2431.
Thomas BJ, Rothstein R. 1989. Elevated recombination rates in 
transcriptionally active DNA. Cell 56: 619-630.
Wahl, M.C., Will, C.L., and Luhrmann, R. 2009. The spliceosome: design 
principles of a dynamic RNP machine. Cell 136: 701-718.
Will, C.L. and Lührmann, R. 2006. Spliceosome structure and function. in RF 
Gesteland, TR Chech, and JF Atkins (ed), The RNA world, 3rd ed Cold Spring 
Harbor Laboratory Press, Cold Spring Harbor, NY: 369-400.
Zenklusen, D., Vinciguerra, P., Strahm, Y., and Stutz, F. 2001. The yeast 
hnRNP-Like proteins Yra1p and Yra2p participate in mRNA export through 
interaction with Mex67p. Mol Cell Biol 21: 4219-4232.
Zenklusen, D., Vinciguerra, P., Wyss, J.C., and Stutz, F. 2002. Stable mRNP 
formation and export require cotranscriptional recruitment of the mRNA export 
factors Yra1p and Sub2p by Hpr1p. Mol Cell Biol 22: 8241-8253.
93
Abbreviations
°C  degree celcius 
5-FOA 5-Fluoroorotic acid
6-AU  6-azauracil
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